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ADCC Antibody-dependent cellular cytotoxicity 
ADP Adenosine diphosphate 
气 APC(s) Antigen presenting cell(s) 
B cell/lymphocyte Bursa-derived (or bursa-equivalent derived) 
cell/lymphocyte 
CAF Citrate-acetone-formaldehyde 
CD Cluster of differentiation 
Ci Curie 
CMI Cell-mediated immunity 
Con A Concanavalin A 
cpm Counts per minute 
CTL(s) Cytotoxic T lymphocyte(s) 
5iCr Chromium-51 
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EtBr Ethidium bromide 
FACS Fluorescence activated cell sorter 
FITC Fluorescein isothiocyanate 
GM-CSF Granulocyte-macrophage colony stimulating factor 
GTCs Green tea catechins 
GTP Green tea polyphenols 
h Hour 
HBSS Hank's balanced salt solution 





HI-FCS Heat inactivated fetal calf serum 
HIV Human immunodeficiency virus 
� HPLC High performance liquid chromatography 






LAK Lymphokine activated killer 
LC50 50% lethal concentration 
LGLs Large granular lymphocytes 
LPS Lipopolysaccharide 
MAC Membrane attack complex 
MAF(s) , Macrophage activating factor(s) 
2-ME 2-Mercaptoethanol 
MHC Major histocompatibility complex 
min Minute 
mM Millimolar 
mRNA Messenger ribonucleic acid 
NK Natural killer 
NO Nitric oxide 
2-NP 2-nitropropane 
NP-40 Nonidet P-40 
O.D. Optical density 
PBS Phosphate buffered saline 
PEC Peritoneal exudate cells 
PI Propidium iodide 
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RNA Ribonucleic acid 
RNase A Ribonuclease A 
ROS Reactive oxygen species 
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culture medium 1640 
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Tea is derived from the leaves of Camellia sinensis, an evergreen shrub in the 
*t 
family of Theaceae. Besides being one of the most popular and widely consumed 
beverage worldwide, tea is traditionally claimed to have various medicinal benefits by the 
Chinese. According to the manufacturing process, there are three main types of tea that 
are available in the market: the green tea, black tea and oolong tea. Green tea generally 
refers to the non-fermented tea. Black tea is known as fermented tea because it is 
manufactured by an enzyme-dependent oxidative fermentation process. Oolong tea is the 
partially fermented tea because the fermentation process is only partially completed. The 
chemical composition of green tea is very similar to that of the fresh tea leaves. The 
major constituents of green tea are the polyphenols, most of which are known as 
flavanols, or tea catechins,^which may account up to 30% of the dry weight of green tea. 
The four major green tea catechins are (-)-epigallocatechin-3-gallate (EGCG),(-)-
epicatechin-3-gallate (ECG), (-)-epigallocatechin (EGC) and (-)-epicatechin (EC). Recent 
researches have shown that most of the medicinal effects of tea are contributed by the 
green tea catechins (GTCs). The diverse physiological and pharmacological effects of 
GTCs are currently under intensive study and they include anti-oxidative, anti-mutagenic, 
anti-carcinogenic, anti-inflammatory, anti-microbial, hypolipidemic and 
hypocholesterolemic activities. However, whether GTCs have any modulatory effect on 
the host immune response and their inhibitory effect on tumours are far from being 
understood. Therefore, the aim of this thesis project is to investigate the 
immunomodulatory and anti-tumour activities of GTCs. 
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In the present study, the bio-toxicity of GTCs was firstly investigated by the brine 
shrimp assay and their general cellular toxicity was tested by incubation with murine 
splenocytes. Our results showed that GTCs were generally non-toxic in nature, and had 
、 
little, if any, cytotoxic effect on murine splenocytes. 
The immunomodulatory activity of GTCs was then examined by various 
immunological assays. GTCs were found to have mitogenic as well as co-mitogenic 
activities on murine splenocytes in vitro. The lymphoproliferative responses of murine 
lymphocytes to T- and B-cell mitogens, as well as to allogeneic antigens were also found 
to be enhanced by the in vivo administration of GTCs. The effect of GTCs on lymphocyte 
functions was also examined. Results showed that the intraperitoneal (i.p.) injection of 
GTCs could slightly enhance the cytotoxic activity of alloreactive cytotoxic T cells on 
allogeneic target cells. Orrthe other hand, GTCs could also significantly enhance the in 
vivo induction of delayed type hypersensitivity (DTH) response mediated by the effector 
T cells against the sheep red blood cells (SRBC). However, the effect of GTCs on B cell 
function was less well-defined as the primary humoral antibody production by B cells 
was only slightly increased by GTCs treatment. 
GTCs were also found to exhibit a stimulatory effect on macrophages, the non-
specific effector cells of the immune system. In vitro study demonstrated that GTCs 
could increase both the phagocytic and cytostatic activities of elicited peritoneal 
macrophages. The i.p. administration of GTCs also exhibited a stimulatory effect on the 
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cytostatic activity of activated macrophages and enhanced the in vivo migration of 
macrophages. 
^ The anti-tumour activity of GTCs was also investigated by using a wide variety of 
tumour cell lines. The in vivo administration of GTCs was found to be inhibitory on the 
growth of two transplantable tumours, WEHI-3B JCS and EAT, in mice. The in vivo anti-
tumour mechanism might be mediated, at least in part, by the activation of the host's cell-
mediated immune response, as the in vitro cytolytic activity of natural killer C^K) cells 
was greatly enhanced by the in vivo treatment of mice with GTCs. Also, the in vitro 
incubation of splenocytes with GTCs could induce the lymphokine activated killer 
(LAK)-like activity as well as augmenting the IL-2-induced LAK cell activity. 
The direct in vzYro,anti-tumour activity of GTCs was assayed using the purified 
epicatechin isomers. The major and the most potent isomer, EGCG, was found to display 
differential anti-proliferative effect on various tumour cell lines, and inhibited the 
clonogenicity of myeloid leukemia cells in vitro. In addition, EGCG could induce DNA 
fragmentation, nuclear disintegration and cell cycle arrest of the human myeloid leukemia 
HL-60 cells. Collectively, the present results indicate that GTCs have potent 
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Chapter 1: General Introduction 
^ 
Chapter 1 Introduction 
1.1 AN OVERVIEW OF THE IMMUNE SYSTEM 
We all live in a world filled with numerous infectious agents such as viruses, 
bacteria, fungi and parasitic worms. To avoid their invasion and to prevent their 
harmful effects on our body, a remarkable adaptive defence system, the immune 
、 
system, has evolved and developed in our body. The immune system is able to 
generate an enormous variety of cells and molecules, which act together in an 
exquisitely adaptable dynamic network, capable of specifically recognizing and 
eliminating an apparently limitless variety of invaders. According to the nature and 
mechanism, the immune system can be divided into two components, innate or non-
specific immune system and specific or acquired immune system (Roitt, 1997). 
1.1.1 Innate Immunity 
The innate immune system is non-specific and is effective against a wide range of 
potential targets. The mechanisms are constitutional and do not improve on repeated 
contact with the same target. The operation of innate immunity requires a cooperative 
network of physical barriers, chemical influences, cellular components and soluble 
humoral factors. 
Ll.1.1 Physical Barriers 
Physical barriers generally refer to the first line of defense that prevent 
penetration of foreign substances into the host. The intact skin is impermeable to most 
infectious agents. The respiratory tract, alimentary tract and the urinogenital tract all 
have an exterior epithelial cell layer covered by a protective mucous lining. In the 
respiratory tract, the mucus traps the pathogens while the cilia propel the mucus-
trapped pathogens towards the nasopharynx so that they are expelled out. 
1 
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LLL2 Chemical Influences 
Chemical influences refer to the secreted products which combat against the 
invaded pathogens. The sebaceous and sweat secretions of skin are acidic and have 
direct inhibitory effects to most bacteria. Many other secreted body fluids also contain 
气 
bactericidal components, such as acid in gastric juice, spermine and zinc in semen, 
lactoperoxidase in milk and lysozyme in tears, nasal secretions and saliva. 
LLL3 Cellular Components 
a. Granulocytic cells 
Granulocytic cells include neutrophils, eosinophils and basophils. Neutrophils are 
generally the first cells to arrive at the site of inflammation by chemotaxis, and 
destroy the pathogens by various enzymes as well as anti-microbial substances 
contained in their granules through phagocytosis. Eosinophils have a major role in 
defense against parasitic organisms by secreting contents of eosinophilic granules 
which cause damage to the parasite membrane. Basophils function by releasing 
pharmacologically active substances such as histamine and prostaglandins which are 
involved in allergic response. 
b. Mononuclear cells 
These include circulating monocytes in blood and macrophages in various 
tissues. Macrophages are differentiated from monocytes and have increased 
phagocytic ability. Resting macrophages can be activated so that the phagocytic 
activity and microbicidal activities are enhanced. The activated macrophages also 
have enhanced ability to secrete inflammatory mediators as well as to activate T cells. 
Besides secreting various cytotoxic proteins to eliminate a broad range of pathogens, 
2 
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activated macrophages can process the phagocytosed antigens and present them to 
lymphocytes, so that the specific immunity is linked with the non-specific one. 
c. Natural killer (NK) cells 
%. 
Natural killer cells are distinct subpopulation of lymphocytes which are 
characterized by the large granular morphology (Whiteside and Herberman, 1995). 
They are thought to recognize structures on high molecular weight glycoproteins 
appearing on the surface of virally infected cells, so that the infected cells can be 
distinguished from normal uninfected cells. Activation of the NK cells causes release 
of the contents in their granules, resulting in cell lysis or apoptotic cell death of target 
cells (Brittenden et al., 1996). 
1.1.1.4 Soluble Humoral Factors 
In the body fluids,^there are various proteins which help combating against 
infection. Lysozyme is a hydrolytic enzyme found in mucous secretions and is able to 
damage the bacterial cell wall. Complement, a series of serum proteins, is activated in 
a controlled enzymatic cascade by a variety of specific and non-specific immunologic 
mechanisms. Their activation results in membrane-damaging reactions, or coating of 
non-self particles, which facilitates phagocytosis and clearance of such pathogenic 
particles. Moreover, a number of plasma proteins, collectively termed acute phase 
proteins, increase in concentration moderately or dramatically in serum during 
infection or tissue injury. The acute phase response is likely to achieve a beneficial 
effect through enhancing host resistance, minimizing tissue injury and promoting the 
resolution and repair of the inflammatory lesion. Interferons (IFN) are a group of 
proteins synthesized in virus infected cells. They are secreted into the extracellular 
’ 
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fluid, bind to specific receptors on infected neighboring cells and trigger synthesis of 
certain enzymes in the target cells. The enzymes can reduce viral mRNA translation 
and degrade mRNA in infected target cells so that the spread of vims can be 
prevented (Riott, 1997). 
*t 
1.1.2 Specific Acquired Immunity 
Unlike innate immunity, specific acquired immunity requires the presence of a 
functional immune system which is able to specifically recognize and selectively 
eliminate foreign substances. It is characterized by features like specificity, diversity, 
memory, and self/non-self recognition. The specific acquired immune response is 
further subdivided into humoral and cell-mediated immune response, both of which 
require interactions among several different cell types to induce a specific 
immunologic response. 
< 
1.1.2.1 Humoral Immune Response 
The humoral immune response involves the B lymphocytes and their products, 
the antibody molecules. B lymphocytes are produced and matured in the bone marrow 
before being released into the blood circulation. When a naive B cell first encounters 
a specific antigen, the B cell receptor (membrane-bound antibody) interacts and 
couples with the complementary antigen. The antigen cross-links the membrane-
bound antibody molecules and is then internalized by the B celL After processing the 
antigen, the B cell presents the antigen together with a class II MHC molecule on its 
membrane to an antigen-specific helper T (1¾ cells. As a result, the Tu cells secrete a 
number of cytokines which serve to stimulate various stages of B cell proliferation 
and differentiation. The activated B cell undergoes a series of cell divisions over 
4 
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approximately a 5-day period differentiating into a population of both effector plasma 
cells and memory cells. The plasma cells do not produce membrane-bound antibody 
but instead produce and secrete enormous amounts of antibodies. Memory B cells, 
expressing membrane-bound antibody with the same specificity as the original parent 
、 
cell, have a longer life span. Due to the presence of amplified memory B cell-
population, a second contact of such B cells with the same antigen will induce a more 
rapid and vigorous clonal expansion and antibody production. This characterizes a 
secondary response and distinguishes it from the initial primary response (Kuby, 
1994). . 
1.1.2,2 Cell-mediated Immune Response 
Many micro-organisms like viruses live inside host cells where they escape from 
the attack by antibodies or the various components of the innate immune system, so 
alternative mechanisms called cell-mediated immunity (CMI) are obviously required. 
Various subpopulations of T lymphocytes are involved in the cell-mediated immune 
response. They recognize specific antigen as foreign molecule after the antigen has 
been processed intracellularly and presented on the host's cell surface in association 
with the major histocompatability complex (MHC). The CD4+ helper T cells (Tn) are 
activated and secrete a variety of cytokines after recognizing antigen associated with 
the class II MHC molecule. The secreted cytokines are responsible for stimulating 
other effector immune cells. The CD8+ cytotoxic T cells (CTL), which recognize 
antigen presented with the class I MHC molecule, are activated by cytokines released 
from helper T cells to cause direct cell lysis of the target cells. Other cell types such as 
B cells, macrophages and NK cells are also activated by cytokines released from Tn 
cells. Like B cells in humoral response, a particular T cell clone is selected and 
5  
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activated by combination with specific antigen. They are expanded by clonal 
proliferation and mature to give helper T cells, cytotoxic T cells, together with an 
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1.2 IMMUNE RESPONSE TO TUMOURS 
The immune system was suggested to play a critical role in preventing tumour 
development by searching out and destroying newly transformed cells as if they were 
foreign cells. This concept of "immunosurveillance" was first proposed by Paul 
I 
Ehrlich in 1909, and was supported by a series of observations that increasing risks of 
certain cancers were associated with immune depression caused by immunodeficiency 
diseases and immunosuppressive treatments (Penn, 1991). Fifteen years later, Lewis 
Thomas also suggested that the cell-mediated branch of immune system had evolved 
to patrol body and eliminate cancer cells, and tumours arose only if cancer cells were 
able to escape the immunosurveillance. However, some other experimental findings 
were difficult to reconcile with this theory. For instance, athymic nude mice which 
lack functional T cells are no more susceptible to spontaneous tumours than other 
normal mice. Nevertheless, it is clear from experimental study and clinical evidence 
that immune response can be generated against tumour cells. The anti-tumour immune 
response includes both specific and non-specific mechanisms involving various 
immune cells and humoral factors. 
1.2.1 Specific Mechanisms 
1.2.1.1 Cellular Immune Response 
Specific cellular anti-tumour immune response depends upon the existence of a 
tumour antigen that can be recognized as “non-self，by the immune system. In the 
activation of CD8+ cytotoxic T cells (CTLs), the endogenously synthesized antigen is 
processed intracellularly within the proteasome into short peptides, which are then 
associated with the class I MHC complex fNee^es and Momburg, 1993). The 
antigenic peptide-MHC class I complex is transported to the cell surface where it is 
7 
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recognized by the T cell receptor (TCR) of a cytotoxic T cell. Full activation of CTL 
for tumour killing requires additional signals provided by the binding of cytokines 
which are released from the activated helper T cells (TH) to their surface receptors. 
The activated CTL is responsible for destroying tumours by secreting toxic substances 
� such as tumour necrosis factor (TNF), or triggering membrane damage and DNA 
degradation of tumour cells (Lancki et al., 1993). 
Activation of CD4+ helper T cells requires presentation of tumour antigen by 
professional antigen presenting cells (APCs), such as dendritic cells, macrophages or 
activated B cells (Paul and Seder, 1994). These APCs take up antigen, process it 
proteolytically via a separate endosomal antigen processing pathway, and present 
antigenic peptide complexed with an MHC class II molecule fNee^es and Momburg, 
1993). The full activation also requires a non-specific additional signal, by interaction 
of co-stimulatory molecule B7 on APC with its ligand CD28 on T cell (Allison, 1994; 
June et al., 1994). Specific TH cells play an important accessory role both in the 
initiation of the immune response, by secretion of cytokines including interleukin-2 
(IL-2) to support the proliferation and activation of CTL; and also in maintenance of 
immunological “memory，，. The Tu compartment may be further subdivided into Tgl 
cells and TH2 cells. The THl cells secrete IL-2, IFN-y, and macrophage activating 
factor (MAF), to support the generation of a cell-mediated CTL response and 
induction of macrophage activation. On the other hand, the Tu2 cells secrete IL-4, 
IL-5, IL-6 and IL-10 for assisting antibody production in a humoral immune response. 
The cytokine IL-12, which is produced by a variety of phagocytic and APCs, 
especially activated macrophages, has been shown to play a pivotal role in favoring 
generation of Tul cells and hence a CMI response, in opposition to IL-4 which 
8 
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promotes generation ofTn2 cells and a humoral response (Trinchieri, 1995). 
1,2.1.2 Humoral Immune Response 
It is generally believed that effective anti-tumour immunity will require a strong 
I 
celullar response in order to kill the tumour cells expressing tumour antigens. 
However, antibody responses, deriving from B lymphocytes with highly specific 
immunoglobluin-mediated recognition of tumour antigens, also play an important role 
in anti-tumour immunity (Knuth et al, 1991). One of the mechanisms of antibody 
response against tumours involves the activation of the complement cascade, leading 
to assembly of membrane attack complex (MAC), pore formation, and complement-
mediated lysis of tumour cells. Certain activated complement components, such as 
C3a and C5a, induce localized mast-cell degranulation and the release of mediators 
that facilitate the influx of inflammatory cells especially neutrophils and macrophages 
(Lloyd, 1991). 
Antibodies binding to tumour cells may also facilitate antibody-dependent 
cellular cytotoxicity (ADCC) (Llyod, 1991). Certain antibody subclasses, particularly 
IgGl and IgG3, are potent mediators which form a bridge between the tumour target 
cell membrane and effector cells, such as NK cells, macrophages and granulocytes, 
which have the receptors for the Fc region of the induced antibodies (Ortaldo et aL, 
1987). Tumour killing by this mechanism involves three phases: (1) binding to the -
target, (2) releasing enzymes that make the target more susceptible to injury, and (3) 
target cell destruction. 
The B cells in humoral response also participate in presentation of tumour 
9 
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antigens to T cells through the class II MHC complex as mentioned previously. 
1.2.2 Non-specific Mechanisms 
1.2.2.1 Natural Killer Cells 
^ Natural killer fNK) cells are a heterogeneous group of large granular 
lymphocytes (LGLs) without expression of membrane-bound immunoglobulin and T 
cell receptor. Despite having no specific receptors like TCR, NK cells appear to be 
able to discriminate between abnormal and normal cells, which depends on the 
presence of at least two interactive receptor systems. The NKR-P1 receptor 
recognizes oligosaccharide moieties on target cells and trigger killing of abnormal 
cells (Benzouska et al., 1994). Another receptor recognizes autologous MHC class I 
molecules expressed on all normal nucleated cells and tums off cytotoxicity triggered 
by NKR-P1 (Karre, 1995). Through this recognition mechanism, NK cells can 
spontaneously lyse tumour cells as “non-self，in a MHC unrestricted way without the 
need for prior sensitization. Mechanisms for tumour killing by NK cells include 
perforin/granzyme-mediated necrosis, secretion of soluble factors such as cytokines, 
and triggering of target cells apoptosis by cell contact or by secreting TNF family 
ligands (Whiteside et al, 1995). Moreover, NK cells have Fc receptors on their 
surfaces which facilitate tumour cell killing through ADCC (Llyod, 1991). 
In the presence of cytokines such as interferons, tumour necrosis factor and IL-2, 
the action of NK cells can be enhanced. It was found that a subset of NK cells, 
activated adherent NK (A-NK) cells, respond rapidly by adhering to solid surfaces 
under the influence ofIL-2. A-NK cells have been found to have a particular capacity 
for extravasation and infiltration of solid tissues, and for mediating anti-tumour 
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surveillance by selectively eliminate abnormal but spare normal tissue cells 
(Whiteside and Herberman, 1995). 
In addtion to tumour cell killing, NK cells can release IFN-y, IL-1 and 
% 
granulocyte-macrophage colony stimulating factor (GM-CSF), which are important in 
regulating immune response and stimulating hematopoiesis (White, 1996). 
1.2.2,2 Lymphokine-activated Killer (LAK) Cells 
The lymphokine-activated killer (LAK) phenomenon was first described in 1982 
as a novel lymphocytotoxic system with many apparent characteristics distinct from 
the NK cells and CTLs. LAK cells are defined as interleukin-2 (IL-2)-activated 
cytotoxic cells capable of lysing NK-resistant fresh human tumours (Grimm, 1986). 
The progenitor cells of LAK are mainly large granular lymphocytes that are T-cell 
receptor/CD3 negative, CD16 positive, and CD56 positive (Herberman, 1987). Also, 
it has been reported that T, B, NK, and null lymphocytes directly respond to purified 
recombinant IL-2 and differentiate into LAK cells. Therefore, LAK cells have been 
proposed not to be a unique cell type, but a function representing only one part of the 
inducible, antigen-non-specific amplification mechanism operative in the normal 
immune response (Ortaldo et al., 1986). LAK cells are not MHC restricted and can 
kill a wide range of target cells including freshly isolated tumour cells (Berke, 1997). 
Like CTLs and NK cells, LAK cells employ both lytic pathways (perforirL/granzyme 
and Fas) in short-term assays, as well as a slow-acting TNF-based lytic mechanism 
(Liu etal., 1995). 
LAK cells were found to be effective against several murine tumours of different  
n  
Chapter 1 Introduction 
histologies and immunogenicities, and their anti-tumour effect was dose dependent 
and required the exogenous administration of IL-2 as an additional treatment. Based 
on these experimental observations, a large number of clinical protocols were 
designed in the 1980s to test the therapeutic efficacy for treatment of mostly 
% 
metastatic melanoma and advanced renal cell carcinoma (Rosenberg and Lotze, 1986; 
Hawkins, 1989). LAK cells have had therapeutic benefit in some patients, but such 
effector cells frequently lack tumour specificity and immunologic memory. Because 
of the requirement for concurrent IL-2 administration, the combined LAK cell-IL-2 
therapy produced unacceptable toxic effects in some treated patients (Appelbaum, 
1992). 
L2,2,3 Tumour Infiltrating Lymphocytes (TILs) 
It has been observed that some cancers are infiltrated extensively by 
mononuclear cells, whereas others are not. The cells that infiltrate and invade tumours 
are known as tumour infiltrating lymphocytes (TILs). Culture and expansion of such 
cells are possible through the use of recombinant IL-2 (Rosenberg et aL, 1988). The 
phenotype and functional status of TILs have been examined in a number of tumour 
types including breast, lung and melanoma. The majority of the infiltrating cells are T 
lymphocytes with both cytotoxic and helper phenotypes present. Only a minor (< 5%) 
portion of the TILs preparation is composed ofNK and macrophages. TILs appear to 
represent part of the host-immune response to the tumour and may contain an 
_^nriched population of cells with reactivity to autologous tumour. Murine tumour 
models showed that TILs are 50 to 100 times more potent in anti-tumour response 
than are similar numbers of LAK cells from peripheral blood (Rosenberg, 1988). 
Moreover, IL-2-activated TILs obtained from some tumours appear to be specifically 
12  
Chapter I Introduction 
cytotoxic for autologous tumour cells and do not lyse allogeneic targets (Becker et al., 
1993; Rosenberg, 1993). 
A limited number of clinical studies have evaluated TILs in the treatment of 
� human malignancy. Combination therapy with TILs, IL-2 and cyclophosphamide has 
shown a 50% response rate in highly selected patients with metastatic melanoma 
(Rosenberg et al., 1988). In a subsequent report that extended this experience to 
patients with melanoma, 34% of these patients experienced objective tumour response 
(Rosenberg et al., 1994). The clinical experience with TILs adoptive immunotherapy 
has demonstrated that tumour-sensitized T cells are potentially effective anti-tumour 
reagents. 
1.2.2.4 Macrophages 
Macrophages are another important effector cell type in the host non-specific 
immune defence against tumours. Like NK cells, macrophages do not recognize 
antigens as well as MHC products. However, accumulating evidence indicates that 
macrophages have the ability to differentiate between normal and transformed or 
virus-infected cells, and to selectively leave normal cells unharmed while killing the 
transformed or infected cells (Fidler et al., 1988). Due to the high level expression of 
MHC class II antigens, macrophages appear to play an important role in the pathways 
of specific anti-tumour immunity, in which they act as antigen presenting cells to 
present the processed tumour antigens to helper T cells to initiate the cellular immune 
response. 
Macrophages can be activated by macrophage-activating factors (MAFs)  
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produced by T cells and NK cells, so that their tumouricidal effects can be enhanced. 
By secreting mediators such as TNF-a and IL-1 (Fidler et al., 1989), activated 
macrophages can cause tumour cell cytostasis, which occurs rapidly and does not 
require cell contact. In addition, after recognition of neoplastic cells, macrophages 
、 
selectively bind to them and secrete toxic substances, such as TNF-a, nitric oxide 
fN"0) (Keller et al., 1990) and a novel serine protease, which result in the eventual cell 
lysis of the tumour targets. ADCC is another mode of tumour killing whereby 
macrophages are able to lyse antibody-coated tumour cells (Hara et al., 1989). The 
binding of the antibody-coated tumour cells to surface Fc receptor on macrophages 
triggers secretion of lytic mediators, such as reactive oxygen intermediates (ROI), 
complement components, neutral protease and TNF-a, which all play an important 
role in cytolysis. 
1.2.2.5 Other Cell Types Mediating Non-specific Immunity 
A variety of other immune cells have been implicated in mediating tumour 
regression, including eosinophils, mast cells and neutrophils. All of these are typically 
recruited to sites of inflammation, in response to cytokine secretion by activated CD4+ 
helper cells and tumour-associated macrophages. The efficacy of eosinophils in 
mediating rejection of rodent tumours has been demonstrated by experiments in 
which tumour cells engineered to express interleukin-4 (IL-4) were shown to be 
rejected in vivo (Tepper et al., 1992). The rejection was accompanied by distinctive 
infiltration of the regressing tumour by eosinophils and macrophages. An interesting 
finding is that short-lived immunological memory, under certain circumstances, was 
produced, which conferred some resistance to subsequent challenge with unmodified 
tumour cells. 
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1.3 PHYTOCHEMICALS AS POTENTIAL IMMUNO-
MODULATORS AND ANTI-TUMOUR AGENTS 
Natural products from plants or phytochemicals have been used in the treatment 
of cancer for over 3500 years (Hartwell, 1967), but it is only since 1959 that a 
%. 
concerted systematic effort has been made to screen crude plant extracts for their 
inhibitory activity against animal tumour systems. In the last four decades, over 
180.000 plant samples representing 4,000 species have been screened by the plant 
screening program conducted under the auspices of the National Cancer Institute 
CNCI) (Lien et al., 1985; Suffness et al., 1991), and they have provided a wide range 
of structures eliciting anti-tumour activity. Of these, several of them had progressed to 
clinical trials and demonstrated efficacy. For example, paclitaxel (Taxol®), vincristine 
(Oncovin®), podophyllotoxin, and camptothecin, which are derived from Taxus 
brevifolia L., Catharanthus roseus G. Don, Podophyllum peltatum L., and 
< 
Camptotheca acuminata Decne respectively, are anti-tumour agents used clinically. 
Use of paclitaxel has been expanded to include a greater variety of cancers and more 
recently, Taxotere® has even received marketing approval by the U.S. Food and Drug 
Administration (Pezzuto, 1997). 
1.3.1 Modulation of the Immune System 
A large number of natural plant products were found to have immunomodulatory 
activities, and some of them exhibit inhibitory effect against tumour through 
stimulation of the host anti-tumour immune responses. Many herbal agents including 
Traditional Chinese Medicine (TCM) have been recently under extensive 
investigation. The polysaccharides isolated from medicinal plants have been shown to 
cause activation of various types of effector cells including B lymphocytes  
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(Kimiazawa et al., 1985a), T lymphocytes (Kumazawa et aL, 1985b), macrophages 
(Wang et al., 1993; Wong et al., 1994), polymorphonuclear cells (Morikawa et al., 
1985), NK cells (Wong et al., 1994; Choy et aL, 1994), LAK cells (Hayashida et al., 
1991; Wong et al., 1994), and TILs (Kariya et al., 1991; Wong et al., 1994). Many 
1, 
anti-tumour polysaccharides can stimulate production of cytokines both in vitro 
(Xiang and Li, 1993) and in vivo (Wong et al., 1994) which exhibit direct anti-tumour 
activities. 
Besides the high molecular weight polysaccharides from the medicinal plants, 
many low molecular weight compounds isolated from plants also exhibit 
immunomodulatory effects. Tannins such as agrimoniin from Agrimonia pilosa and 
oenotheins from Oenothera erythrosepala, have recently been found to have host-
mediated anti-cancer activity through stimulation of macrophages in vitro and in vivo, 
induction ofIL-1 production and activation of cytotoxic inununocytes (Miyamaoto et 
al., 1997). Flavonoids, a large group oflow molecular weight polyphenolic secondary 
plant metabolites, have also been found to have various effects on immune cells 
including lymphocytes, NK cells and macrophages etc. Their diverse effects on the 
immune system have been reviewed in details elsewhere (Middleton et al., 1992). 
1.3.2 Induction of Cancer Cell Differentiation 
The progression of some malignancies is thought to be due to a block in cell 
differentiation. Agents that can induce differentiation of malignant cells, leading to 
their development into normal cells and loss of their ability to proliferate, may be 
useful in treating these malignancies (Breitman, 1990). A number of natural plant 
products have been found to have the ability to induce differentiation in different 
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cancer cell types. For instance, Daidzein, an isoflavone found in legumes such as 
Pueraria lobata ( ) and in soy products, induced differentiation in B16 
melanoma and HL-60 human leukemia cells (Jing et al., 1993; Jing and Han, 1992). 
Berberine, an alkaloid found in Coptis chinensis ( ) and a number of other 
V 
herbs, induced differentiation of the human embryonal carcinoma cells which was 
associated with the down-regulation of the ras proto-oncogene {c-YA-ras2) (Chang et 
al., 1990; Chang, 1991). More recently, extracts from Citrus reticulata were shown to 
be capable of inducing the differentiation of th& murine myeloid leukemia JCS cells 
into mature macrophage-like or PMN-like cells and was associated with reduction in 
the in vivo tumourigenicity of the cells (Mak et al., 1996). 
1.3.3 Stimulation of Apoptosis 
Apoptosis is a physiologic and pathologic process, in which an endogenous 
suicide mechanism is triggered within a cell leading to self-destruction in an ordered 
series of events (Wyllie et al., 1980; Marx, 1993). Therefore, it functions as an 
essential mechanism of tissue homeostasis (Meikrantz and Schlegel, 1995). It has 
been suggested that tumour growth depends on evasion of this normal control 
mechanism that operates through a programmed deletion of cells with DNA damage 
(Schwartzman and Cidlowski, 1993), so that the initiated cells are allowed to survive 
long enough to progress to the irreversible promotion and proliferation stage. 
Some natural plant products were reported to have the ability of inducing 
apoptosis in cancer cells. Genistein, an isoflavone found in legumes, was found to 
induce apoptosis the human T leukemia Jurkat cells (Spinozzi et al., 1994), human 
myelogenous leukemia HL-60 cells and the human lymphocytic leukemia MOLT-4 
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cells (Traganos et al., 1992). Quercetin is a flavonoid that was found to induce 
apoptosis in human leukemia K562 cells and MOLT-4 cells as well as the Burkitt's 
lymphoma Raji cells (Wei et aL, 1994). 
、 
1.3.4 Other Anti-tumour Mechanisms 
Natural plant products can exhibit anti-tumour activities through other 
mechanisms. Some of them are able to inhibit angiogenesis (Fotsis et al., 1993) so as 
to restrict the blood supply to the established tumours. Through inhibiting the protease ~ 
activities, invasion of the tumour cells can be inhibited (Makimura et aL, 1993). Some 
agents were also shown to inhibit the metastatic process of malignancy (Tangiuchi et 
aL, 1992). 
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1.4 GREEN TEA: GENERAL PROPERTIES AND 
PHARMACOLOGICAL ACTIVITIES 
1.4.1 General Introduction to Tea 
V 
Tea is derived from the leaves of Camellia sinensis, an evergreen shrub in the 
family of Theaceae (Fig. 1.1), which is grown in about 30 countries. Next to water, 
tea is the most popular and widely consumed beverage worldwide. Based on the 
distinct manufacturing processes, tea can be classified into three main types, namely, 
the green tea, black tea and oolong tea. It is estimated that 2.5 million metric tons of 
dried tea are manufactured annually. Of this amount, about 20% is green tea. Green 
tea generally refers to the non-fermented tea which is produced in relatively few 
countries, and is consumed primarily in China, Japan, India and a few countries in 
North Africa and the Middle East, where tea is a major beverage. About 78% of the 
< 
world's tea consumption is the beverage prepared from black tea, the fermented tea 
which is generally consumed in the Westem countries and some Asian countries. The 
remaining 2% are oolong tea, a partially fermented product which is mainly produced 
and consumed in south-eastern China and Taiwan (Katiyar and Mukhtar, 1996). 
Commercial green tea is made by steaming or drying fresh tea leaves and buds at 
elevated temperatures, and its chemical composition is similar to that of fresh tea 
leaves. In the manufacture ofblack tea, the tea leaves are withered, macerated (rolled) 
and dried, during which an enzyme-dependent oxidative fermentation process occurs. 
In a similar way, oolong tea is manufactured by a partially fermentation process 
(Mukhtar, et aL, 1994; Stoner and Mukhtar, 1995). 
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Fig 1.1 Green Tea Plant (Camellia Sinensis)  
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1.4.2 Chemistry ofTea 
The commercially available green tea has a similar chemical composition to that 
of fresh tea leaves. Over 30% of the dry weight of green tea are polyphenols, which 
include flavanols, flavandiols, flavonoids, and phenolic acids. Among them, the 
� flavanols, commonly known as catechins, are the major components. The major green 
tea catechins (GTCs) are (-)-epigallocatechin-3 gallate (EGCG), (-)-epicatechin 
gallate (ECG), (-)-epigallocatechin (EGC), and (-)-epicatechin (EC), which account 
for greater than 50% of the total polyphenol mixture (Fig. 1.2) (Ho et al., 1993). The 
chemical structures of these compounds are shown in Fig. 1.3. Other chemical 
components of green tea include caffeine, theobromine, theophylline, alkaloids, and 
phenolic acids such as gallic acids and characteristic amino acids such as theanine. A 
comparison of the principal components of green and black tea beverages is 
summarized in Table 1.1. 
^ 
Table 1.1: Principal Components of Green and Black Tea Beverages 
Components Green tea Black tea 
(% w/w)  
Catechins 30-42~~— JTIo 
Theaflavins 0 2-6 
Simple polyphenols 2 3 
Flavonols 2 1 
Other polyphenols 6 23 
Theanine 3 3 
Amino acids 3 3 
Peptides/Protein 6 6 
Organic acids 2 2 
Sugars 7 7 
Other carbohydrates 4 4 
Caffeine 3-6 3-6 
Potassium 5 5 
Other minerals/ash 5-8 5-8 
Adapted from Balentine, 1997 ~~  
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Fig. 1.2: Composition of the Green Tea Polyphenol Fraction 
(Adapted from Ho et al., 1993) 
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Fig. 1.3: Chemical Structures of Green Tea Catechins 
(Adapted from Yang and Wang, 1993) 
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Since the 5- and 7-dihydroxy groups and 1-oxygen atom of the flavanol structure 
make the carbons at positions six and eight strongly nucleophilic, therefore, during 
enzymatic oxidation or non-enzymatic oxidation, including autoxidation or coupled 
oxidation, tea flavanols may undergo oxidative condensation via either C-0 or C-C 
、 
bond formation in oxidative polymerization reactions. This is the chemical basis of 
manufacturing of black tea from tea leaves, in which the monomeric flavan-3-ols 
undergo oxidative polymerization catalyzed by the enzyme polyphenol oxidase, 
leading to the formation of bisflavanols, theaflavins, theambigins, and other 
oligomers. Theaflavins, which constitute about l%-2% of the total dry matter ofblack 
tea, include theaflavin, theaflavin-3 -0-digallate, theaflavin-3 ‘ -0-gallate, and 
theaflavin-3 ‘ ,3-0-digallate. These compounds possess benzotropolone rings with 
dihydroxy or trihydroxy substitution systems, which give the characteristic color and 
taste of black tea. About 10%-20% of the dry weight of black tea is due to 
theambigens, —which are even more extensively oxidized and polymerized, have a 
wide range of molecular weights, and are less well characterized. The structures of 
these two groups of components are shown in Fig. 1.4. 
Oolong tea, the partially fermented product, contains original monomeric 
catechins, theaflavins, and theambigins. Some characteristic components, such as 
epigallocatechin esters, theasinensins, dimeric catechins, and dimeric 
- proanthocyanidins, are also found in oolong tea (Yang and Wang, 1993). 
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Fig. 1.4: Chemical Structures of Oxidized Products of GTCs 
(Adapted from Yang and Wang, 1993) 
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1.4.3 Physiological and Pharmacological Effects of Green Tea Catechins 
The medicinal uses of tea have a very long history and were first reported by 
Chinese scholars in a text written by Pen T'sao circa 24 to 221 AD. (Balentine, 1997). 
Despite the reported harmful effect of caffeine, tea does possess many beneficial 
气 
effects to humans, and most of them are contributed by GTCs. It has been reported 
that GTCs have a wide range of physiological and pharmacological properties 
including anti-oxidative, anti-mutagenic, anti-carcinogenic, anti-inflammatory, anti-
microbial, hypolipidemic and hypocholesterolemic, and many other pharmacological 
activities (Lunder, 1992). 
1,4,3,1 Anti-oxidative activity 
The anti-oxidative activity of green tea has been under extensive investigation. 
The catechins EGCG, EGC and ECG were found to be able to significantly inhibit 
Fe3+/ADP supported spontaneous as well as photo-enhanced lipid peroxidation in 
mouse epidermal microsomes (Katiyar et al, 1994). Terao and co-works (1994) also 
demonstrated that EC and ECG are powerful antioxidants against oxygen radical-
induced lipid peroxidation in phospholipid bilayers. In vivo studies also supported that 
GTCs are powerful antioxidants. Dietary catechins significantly reduced the level of 
oxidative damage in plasma and erythrocytes of rats fed with high polyunsaturated fat 
(30% perilla oil) fNanjo et aL, 1993). Oral administration of green tea was also shown 
to inhibit the formation of 8-hydroxydeoxyguanosine in rat liver nuclear DNA caused 
by 2-nitropropane (2-NP) (Hasegawa et al, 1995). — 
It has been suggested that the antioxidative property" of GTCs is due to the 
presence of the or^/zo-dihydroxy (3',4'-OH) substitution on the B ring of catechins,  
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which make GTCs as strong chelators of metal ions which are required for generation 
of reactive oxygen species (ROS). Besides, GTCs are also strong scavengers against 
ROS, such as superoxide anion radicals and hydroxyl radicals, which can damage 
DNA and other cellular molecules and can initiate lipid peroxidation reactions. Tea 
、 
flavanols can react with peroxy radicals and thus terminate lipid peroxidation chain 
reactions (Yang et al., 1993; Katiyar et al., 1996). 
1.4.3.2 Anti-mutagenic activity -
There are many studies demonstrating the anti-mutagenic activity of green tea 
and its catechin components. Water extracts of green tea and its polyphenols were 
found to significantly inhibit the mutagenicity induced by benzo[a]pyrene, aflatoxin 
Bi, 2-aminofluorene, and methanol extracts of coal tar pitch in bacterial or 
mammalian cell test system (Wang et aL, 1989). Tea extracts were also shown to 
inhibit N-methyl-N'-nitro-N-nitrosoguanidine-induced mutagenicity in vitro as well 
as in intragastric tract of rats (Jain et al., 1989). 
In vivo studies showed that oral feeding of rats with green tea extracts prior to 
administration of aflatoxin Bi to rats could inhibit chromosomal aberrations in bone 
marrow cells (Ito et al., 1989). Similarly, oral administration of green tea polyphenols 
before an intraperitoneal injection of mitomycin C significantly reduced micronucleus 
formation in mouse bone marrow (Imanishi et al., 1991). -
1.4.3.3 Anti-carcinogenic activity 
In 1991, the Working Group of the International Agency for Research on Cancer 
(IARC) reviewed the relationship between the consumption of tea and cancer 
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incidence. However, no consistent and conclusive results were yielded from the 
epidemiological studies (Table 1.2). It was suggested that the inconsistencies might be 
attributed to the consumption of salted or very hot tea, geographical location, use of 
tobacco and alcohol, and lack of information on the type of tea being consumed fNCI, 
、 
DCPC, Chemoprevention Branch and Agent Development Committee, 1996). 
In several laboratory studies, tea (water extracts prepared by boiling green and 
black tea in water and then extracting without use of any solvents), GTP, and EGCG 
have been reported to inhibit carcinogenesis induced by a wide variety of carcinogens 
using initiation, promotion, and progression protocols in numerous rodent cancer 
models fNCI, DCPC, Chemoprevention Branch and Agent Development Committee, 
1996). Green tea and its polyphenol fractions have demonstrated cancer 
chemopreventive activity in various organ sites including colon, duodenum, 
esophagus, forestomach,large intestine, liver, lung, mammary glands, and skin fNCI, 
DCPC, Chemoprevention Branch and Agent Development Committee, 1996). The 
published efficacy of tea compounds is summarized in Table 1.3. 
The possible biochemical mechanisms underlying the cancer protecting activity 
by green tea were also examined in a number of animal studies. Overall, the 
mechanisms identified span the whole process of carcinogenesis, from the formation 
and activation of carcinogens, through cancer initiation, promotion and progression, 
to diminished tumour growth and metastatic spread. The proposed mechanisms of 
anti-carcinogenic activity of tea are summarized in Table 1.4 (Ivor et al., 1996). 
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Table 1.2: Summary of the Epidemiological Studies Conducted in Relationship to  
Tea Consumption and Human Cancer Risk  
Target organ Association of tea drinking IYpe of study (number of studies) 
with cancer A = Ecological 
B = Cohort 
C = Case-control 
Bladder No relationship A(1), B(2) ,C(16) 
V 
Breast Positive A(1) 
No relationship C(5) 
Negative A(1) 
Colon and rectum Positive A( 1 )，B(1) 
No relationship B(1), C(5) 
Negative C(5) 
Esophagus Positive A(3) 
Positive (high temperature, salted tea) A(4) 
No relationship 
(normal or hot temperature tea) C(7) 
Negative A(1), C(6), B(1) 
Gall bladder Negative C(1) 
Kidney Positive B(1), C(1) 
No relationship C(7) 
No relationship (Wilms tumours, B(1) 
matemal consumption) 
Negative B(1) 
Leukemia No relationship A(1) 
Liver No relationship A(1), B(1), C(1) 
Negative A( 1) 
Lung - Positive A(1), B(1) 
No relationship C(2) 
Negative A(1), C(1) 
Nasopharynx oropharynx (oral Positive C(1) 
cavity, mouth, tongue) No relationship C(3), A(1) 
Negative C(1) ,B(1) 
Ovary No relationship A(1) 
Pancreas Positive C(1) 
Positive (green tea) C(1), B(3) 
No relationship A(1), C(7) 
No relationship (black tea) B(2X C( 1) 
Negative C(2) 
Prostate No relationship C(1), B(1) 
Stomach Positive B( 1)’ C( 1)’ A( 1) 
No relationship C(8), A(2), C(4) 
Negative B(1) 
Uterus Negative A(2) 
Association with drinking tea: Positive: increased cancer incidence with tea intake; 
Negative: decreased cancer incidence with tea intake; No relationship: tea intake had 
no effect on cancer incidence. (Modified from NCI, DCPC Chemoprevention Branch 
and Agent Development Committee, 1996) 
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Table 1.3: Summary of the Preclinical In Vivo Efficacy Studies on the 
Chemopreventive Effects of Tea Against Carcinogen-induced 
Tumourigenesis. 
Target organ Species Carcinogen Tea compoundf Dose Result 
Colon F344 rat AOM GTP 0.01,0.1% + 
Colon F344rat MNU GTP 0.002,0.01,0.05% + 
� Duodenum C57BL/6 mice ENNG EGCG 0.005%(ca 0.016 + 
mmol/kg-bw/day) 
Esophagus Wistar rat Sodium nitrite + Various black, 0.5-1 g dried tea + 
methyl- green tea water 
benzylamine extracts 
Esophagus Rat MBN Various black, 2% + 
green tea water 
extracts 
Forestomach A/J mice B(a)P, DEN GTP, WEGT GTP: 0.2% + 
- WEGT: 2.5% 
Forestomach A/J mice DEN WEGT 0.63%, 1.25% + 
Large intestine Kunming mice DMH GTP, EGCG 1-3 mg/mice ig + 
(EGCG: 2 mg/ 
mice, ca. 0.12 
mmol/kg-bw/day) 
Liver Wistar rat DEN Green tea 2.5% in diet + 
Liver C3H/HeN mice Spontaneous EGCG 0.05%, 0.1%(ca. + 
0.16-0.32 
mmol/kg-bw/day) 
Lung A/J mice B(a)P, DEN GTP, WEGT GTP: 0.2% + 
^ WEGT: 2.5% 
Lung A/J mice NNK Decaffeinated 0.3%, 0.6% + 
WEGT, WEBT 
Mammary Sprague-Dawley DMBA GTP 1% in diet + 
glands rat 
Mammary F344 rat PhIP GTP 1% in diet + (tumour 
glands size only) 
Multiorgan F344 rat DEN + MNU + GTP 0.1 %, 1 % in diet + (intestine) 
carcinogenesis DMH + BBN + 
model (colon, DHPN 
lung, small 
intestine) 
Skin SENCARmice DMBA/TPA GTP lOmg/0.2 ml + 
acetone, top or 0.5 
g/1 in H2O 
Skin CD-1 mice DMBA/ EGCG 5 mg/mice, top (ca +  
Teleocidin 0.011 mmol)  
卞 GTP: green tea polyphenols; EGCG: Epigallocatechin gallate; 
WEGT: water extract of green tea; WEBT: water extract ofblack tea 
本 
Agent administered in or as sole source of water, unless otherwise noted (Modified 
from NCI, DCPC, Chemoprevention Branch and Agent Development Committee, 
1996) 
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Table 1.4: Possible Mechanisms for Cancer Protection by Tea and Its Catechin 
Components 
Protective mechanism Evidence Tea type Active agent(s) 
Initiation 
Reduced carcinogen Decreased formation ofaromatic Green, black EGCG, theaflavin 
formation amines in vitro and reduced 
nitrosamine in urine after NaNO2 
X and proline consumption 
Reduced carcinogen Diminished cytochrome P-450 Green EGCG 
activation and aryl hydrocarbon 
hydroxylase activity 
Increased carcinogen Increased phase 2 enzymes Green Extracts 
detoxification 
Reduced carcinogen- Decreased binding of several Green Extracts, EGCG 
DNA binding carcinogens to DNA 
Antioxidant function Reduced DNA base Green, EGCG 
hydroxylation by oxidizing 
• carcinogen 
Reduced DNA Diminished DNA methylation by Green, black Extracts, EGCG 
alkylation carcinogen 
Promotion 
Reduced promoter Diminished activation of protein Green Extracts, EGCG 
binding kinase C and ornithine 
decarboxylase by promoters and 
reduced inhibition of protein 
phosphatases by okadaic acid; 
reduced binding of estrogen to 
receptors 
Protect cell-cell Reduced inhibition of gap Green ECG, EGCG 
communication junction-mediated 
communication by promoters 
Reduced Enhanced antioxidant activity Green, black ECG, EGC, EGCG, 
Iipoperoxidation against hydroperoxide-induced theaflavin, 
lipoperoxidation thearubigen 
Progression 
Diminished malignant Reduced chemically induced Green Extracts 
conversion malignant transformation of 
papillomas to carcinomas 
Diminished tumour Increased topoisomerase and Green ECG, EGCG 
growth DNA cleavage in vitro 
Reduced metastasis Diminished metastasis o f B l 6 Green EGCG 
melanoma cells in vivo 
(Modified from Ivor et al., 1996) 
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1.4.3.4 Anti-inflammatory activity 
The anti-inflammatory effects of tea and catechins have been demonstrated by 
numerous experiments using animal models. The skin application of green tea 
polyphenols (GTP) to SENCAR mice was found to result in significant prevention 
*, 
against 12-0-tetradecanolyphorbol-13-acetate (TPA)-induced effects on 
cyclooxygenase and lipoxygenase activities, the enzymes which play a role in 
inflammatory response. In addition, the TPA-induced epidermal edema and 
hyperplasia was also inhibited by GTP (Katiyar et al., 1992; 1993). On the other hand, 
GTP was found to possess chemopreventive effects against ultraviolet B (UVB)-
radiation-caused inflammatory changes in murine skin such as cutaneous edema and 
depletion of anti-oxidant-defence system in epidermis (Mukhtar et al., 1996). Results 
showed that oral feeding of GTP could prevent UVB radiation-caused induction of 
both epidermal ornithine decarboxylase and cyclooxygenase activities (Agarwal et al., 
1993). 
1.4.3.5 Hypocholesterolemic and hypolipidemic activities 
Several epidemiological studies showed that drinking tea had an inverse 
association with plasma lipid levels, suggesting the protective effect of tea drinking 
against cardiovascular disease. An epidemiological study in Japan showed a 
significant plasma cholesterol lowering effect of green tea drinking (Kono et al., 
1992). On the other hand, GTCs were also shown to have a lowering effect of plasma 
cholesterol in animal studies. Consumption of mixed catechins (Muramastu et al., 
1986), catechin (Valsa et al., 1995) or EGCG (Chisaka et al., 1988) decreased serum 
cholesterol levels in rats and mice fed with atherogenic diet. The absorption of dietary 
cholesterol was also shown to be inhibited by feeding catechins at levels of 1 to 2  
^  
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g/100 g diet (Chisaka et al” 1988). This effect may be attributed to the precipitation of 
cholesterol in mixed micelles in the presence of high levels of catechins, thus 
reducing cholesterol absorption (Ikeda et al., 1992). 
^ 
1.4.3,6 Anti-microbial activity 
Green tea and its catechin components were shown to possess anti-microbial 
activities in several in vitro and in vivo studies, suggesting that the GTCs may have 
additional beneficial effects to human health. For examples, green tea extracts and 
catechins, especially EGCG, were found to have anti-fungal activity against 
Trichophyton (Okubo et aL, 1991). The catechins were also shown to have 
bacteriostatic and bacteriocidal effects against methicillin-resistant Staphylococcus 
aureus (Toda et al., 1991), and these anti-bacterial activities may be attributed to the 
damage of lipid bilayer by catechins (Ikigai et al., 1993). In addition, GTCs were also 
reported to exhibit inhfbitory effects on the infectivity of rotavirus, enterovirus 
(Mukoyama et al., 1991), and influenza virus fNakayama et al., 1994)，through viral 
agglutination and reduced viral absorption to the target cells. Nakane and Ono (1990)， 
on the other hand, showed that two green tea catechins ECG and EGCG, but not EC 
and EGC, exhibited differential inhibitory effects on the human immunodeficiency 
vims (HIV) reverse transcriptase and cellular DNA and RNA polymerases, thus 
inhibiting HIV replication. 
’ ^ 
J J 
Chapter I Introduction 
1.5 AIMS AND SCOPES OF THIS INVESTIGATION 
Tea is a very popular beverage consumed worldwide. It is derived from the fresh 
leaves of the tea plant Camellia sinenesis, and has long been claimed to have various 
health-promoting effects. In the recent decades, numerous epidemologic and 
I 
laboratory studies have demonstrated that green tea, the non-fermented tea, possesses 
various beneficial physiological and pharmacological activities, and such beneficial 
effects are mainly due to a group of polyphenols which are commonly known as green 
tea catechins (GTCs). Among the medicinal effects of GTCs, the anti-oxidative and 
the anti-carcinogenic effects of tea are currently under intensive investigation. Tea is 
now regarded as a good chemopreventer, but its therapeutic potential in 
immunomodulation as well as cancer treatment has not been fully explored. 
Therefore, the major aim ofthis thesis project is to investigate the immunomodulatory 
and anti-tumour activities of GTCs. 
< 
In the present study, GTCs, which are extracted from the Chinese green tea 
(極品育！^井），will be firstly examined for the bio-toxicity using the brine shrimp 
assay, and the cellular cytotoxicity by trypan blue dye exclusion method. Then the 
immunomodulatory activity of GTCs will be investigated. In particular, the effects of 
GTCs on lymphocyte proliferation and function will be studied both in vitro and in 
v/vo. Moreover, the modulatory effect of GTCs on both the function and migration of 
macrophages, the major non-specific effector cells of the immune system, will be 
examined. 
Moreover, the anti-tumour activity of GTCs will be investigated. GTCs will be 
examined for their effect on the growth of two transplantable tumours, WEHI-3B JCS  
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and EAT, in mice. Since the anti-tumour activity can be mediated through modulating 
the host's anti-tumour immune response, therefore, the effects of GTCs on the non-
specific cytotoxic effector cells such as NK and LAK cells will be studied. Finally, 
attempts will be made to study the anti-tumour activity of GTCs in vitro, using 
%. 
purified epicatechin isomers. In particular, the effect ofEGCG, the major component 
of GTCs, on the proliferation of various cultured tumour cell lines will be assessed. In 
addition, EGCG will be studied for its effects on the clonogenicity, differentiation as 
well as the cell cycle kinetics of myeloid leukemia cells. Whether EGCG can induce 
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2.1 Materials 
2.1.1 Animals 
Inbred female BALB/c (H-2^) and C57BL/6J (H-2^) mice were bred at the Animal 
、 
House of The Chinese University of Hong Kong. They were fed with animal diet (Chow 
5001，Rodent Laboratory) and given tap water ad libitum. Female BALB/c mice aged 6-8 
weeks were used in each experiment except as indicated. 
2.1.2 Cell Lines 
Fibroblast4ike Tumours: 
L929, a transformed murine fibroblast cell line derived from C3H/An mice, was kindly 
obtained from the Department of Pathology, University of Cambridge, U.K. WEHI-164, 
a methylcholanthrene-induced fibrosarcoma derived from BALB/c mice, was purchased 
from the American Type Culture Collection (ATCC), U.S.A. 
Myeloid Tumours: 
WEHI-3B D', a mineral oil-induced murine myelomonocytic leukemia cell line 
derived from BALB/c mice, was originally obtained from Dr. D. Metcalf (Walter and 
Eliza Hall Institute for Medical Research, Melbourne, Australia) and subsequently 
subcloned and maintained at the John Curtin School of Medical Research, Australian 
National University, Canberra, Australia. One of the subclones was designated as WEHI-
3B (JCS) (Leung et al.’ 1994). Ml, a murine myeloblastic leukemia cell line derived 
from a spontaneous myeloid leukemia of SL mice (Ichikawa, 1969), was kindly obtained  
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from the Experimental Hematology Group, the John Curtin School of Medical Research, 
Canberra, Australia. HL-60, a human promyelocytic leukemia cell line originated from a 
36-year-old Caucasian female (Collins et al. 1977), was purchased from ATCC. 
、 
Macrophage-like Tumours: 
PU5-1.8, a murine spontaneous macrophage-like tumour derived from BALB/c 
mice, was obtained from the Department of Pathology, University of Cambridge, U. K. 
P388D1, a methylcholanthrene-induced macrophage-like tumour derived from DBA72 
mice, was purchased from ATCC. 
Lymphoid Tumours: 
MBL-2, a Moloney leukemia virus-induced T cell lymphoma derived from ^ 
C57BL/6J mice, was obtained from the Department of Pathology, University of 
Cambridge, U.K. YAC-1, a Moloney virus-induced T cell lymphoma derived from A/Sn 
mice, was purchased from ATCC. 
Mouse Carcinoma: 
EAT (Ehrlich ascites tumour), an ascites derivative of a spontaneous murine 
mammary adenocarcinoma (tetraploid subline Ny Klein strain), was kindly obtained from 
Prof. K. P. Fung, Department ofBiochemistry, The Chinese University of Hong Kong. 
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2.1.3 Green Tea Catechins and Epicatechin Isomers 
Green tea catechins (GTCs) purified from the Chinese green tea ( 極 品 ^ 井 ) 
were kindly provided by Prof. Z.Y. Chen, Department of Biochemistry, The Chinese 
V 
University of Hong Kong. The GTCs were freshly prepared by dissolving in phosphate-
buffered saline (PBS) or plain RPMI medium as 10 mg/ml just before use. The green tea 
epicatechin isomers ECG, EGCG, EGC and EC were purchased from Sigma Chem. Co. 
(U.S.A.). They were dissolved in ethanol as 20 mg/ml stock solution and then diluted 
with complete RPMI medium just before use. The final concentration of ethanol in the 
culture medium was never exceed 0.1% (v/v). 
2.1.4 Recombinant Murine Interleukin-2 (rmIL-2) 
rmIL-2 was obtained from Boehringer Mannheim (Germany). It was derived from 
E. coli and and with a specific activity 2 x 10^  untis/mg. One unit of rmIL-2 is defined as 
the amount required to support half-maximal stimulation of cell proliferation with the IL-
2-dependent cell line CTLL-2. 
The recombinant IL-2 was prepared in sterile PBS containing 2% heat-inactivated 
fetal calf serum (HI-FCS). It was stored as small volume aliquots of stock solution at -
20°C and allowed to thaw once. The working solution was kept at 4�C and used within 
one month. 
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2.1.5 Antibodies 
Fluorescein Isothiocyanate (FITC)-Conjugated GoatAnti-Rat IgG Antibody 
FITC conjugated goat anti-rat IgG antibody was purchased from Southern 
V 
Biotechnology Associates Inc. (U.S.A.). The purified antibody reacts specifically with rat 
IgG and does not react with other heavy chain isotypes. The antibody was stored as small 
volume aliquots at 4°C before use. 
Fluorescein Isothiocyanate (FITC) Conjugated Mouse Anti-Rat IgMAntibody 
FITC-conjugated mouse anti-rat IgM antibody (clone G53-238, mouse IgG! 
isotype) was obtained from Pharmingen (U.S.A.). The purified antibody reacts 
specifically with rat IgM and does not with other heavy chain isotypes. It was stored as 
small volume aliquots at 4°C before use. 
r-
Monoclonal RatAnti-mouse B Cell-Antigen Antibody 
Monoclonal rat anti-mouse B cell antigen antibody (LR-1, clone LR6.2B6D.C9， 
rat IgM isotype) was purchased from Serotec Ltd. (U.K.) and was stored at a dilution of 
1:50 in PBS supplemented with 2% HI-FCS at -20�C until use. 
Monoclonal Rat Anti-Mouse CD_3 Antibody 
Monoclonal rat anti-mouse CD-3 antibody (clone #29B, rat IgG2b isotype) was 
purchased from GIBCO BRL Life Technologies Inc. (U.S.A.) and was stored as small 
volume aliquots at 4°C until use. 
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2.1.6 Buffers, Culture Medium and Other Reagents 
Culture Medium 
RPMI 1640 medium powder with 2 mM L-glutamine and 25mM N-2-hydroxy-
I 
ethyl-piperazine-N'-2-ethane-sulfonic acid (HEPES) was purchased from GIBCO BRL 
Life Technologies Inc. One litre culture medium was prepared by dissolving 16.2 g of 
powder in distilled water and buffered with 2 g sodium bicarbonate fNaHCO3). The 
solution was then adjusted to pH 7.2, sterilized by membrane filtration through a 0.22 ^m 
millipore filter and stored at 4�C until use. RPMI medium supplemented only with 1% 
antibiotics was designated as "plain medium" and was usually used in cell washing. The 
plain medium supplemented with 10% fetal calf serum was designated as "complete 
medium" and was used for in vitro cell culture. 
r-
Serum Supplements 
Fetal calf serum (FCS) (GIBCO BRL Life Technologies Inc.) was stored as 10 or 
20 ml aliquots at -20T until use. Heat-inactivated fetal calf serum (HI-FCS) was 
prepared by heating the FCS aliquots at 56�C for 30 minutes (min). 10% HI-FCS was 
usually used as a serum supplement for cell-mediated cytotoxicity assays. 
Antibiotic Solution 
Penicillin-Streptomycin-Fungizone (PSF) (GIBCO BRL Life Technologies Inc.) 
100X stock solution containing 10,000 units/ml penicillin G sodium, 10,000 ^ig/ml 
streptomycin sulfate and 25 ^ig/ml amphotericin B as Fungizone was stored as 5 ml 
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aliquots at -20。C until use. The 5 ml aliquot was usually added to 500 ml R P M I medium 
as plain medium. 
气 
Dulbecco,s Phosphate Buffered Saline (PBS) 
PBS (Sigma Chem. Co.) was prepared by dissolving the salts (0.2 g monobasic 
potassium phosphate, 0.2 g potassium chloride, 8 g sodium chloride and 1.15 g 
anhydrous dibasic sodium phosphate) in one litre of double distilled water. The solution 
was adjusted to pH 7.4, and then sterilized by autoclaving at 121。C for 15 min. 
Hank's Balanced Salt Solution (HBSS) 
HBSS was prepared by dissolving 0.4 g potassium chloride, 0.06 g monobasic 
potassium phosphate, 8.19 g sodium chloride, 0.35 g sodium bicarbonate, 0.04 g 
< 
anhydrous dibasic sodium phosphate and 1 g D-glucose in one litre of double distilled 
water. The solution was adjusted to pH 7.4 and then sterilized by membrane filtration 
through a 0.22 ^ m millipore filter. 
Normal Saline 
Normal saline was prepared by dissolving 9 g sodium chloride in one litre of 
double distilled water and sterilized by autoclaving at 12TC for 15 min. 
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Trypsin-EDTA Solution 
Trypsin-EDTA solution, containing 0.25% trypsin and 1 m M EDTA-tetrasodium 
in HBSS without Ca〗+ and Mg〗+ ions, was purchased from GIBCO B R L Life 
、 
Technologies Inc. 
Picolinic Acid (PLA) 
PLA (Sigma Chem. Co.) was freshly prepared in PBS just before use. 0.4 ml of 
the PLA solution was injected intraperitoneally (i.p.) into each BALB/c mouse with a 
body weight of 25 g so that the dosage was 100 mg/kg. 
Thioglycollate (TG) Broth 
3 % T G broth was prepared by dissolving 3 g dehydrated thioglycollate powder 
^ 
(Difco Lab., U.S.A.) in 100 ml double distilled water. The solution was heated at 60。C to 
dissolve the powder and sterilized by autoclaving at 12TC for 15 min. It was stored at 
room temperature in dark for at least one month before use. 
Protease Peptone (PP) Solution 
10% PP solution was prepared by dissolving 10 g protease peptone powder (Difco 
Lab.) in 100 ml PBS. The solution was then sterilized by autoclaving at 12TC for 15 min 
and stored at 4°C until use. 
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RedBloodCells(RBC) 
Sheep red blood cells (SRBC) in Alsever's solution were purchased from Serotec 
Ltd. and maintained at 4。C. The cells were washed with PBS for three times before use. 
%. 
Ficoll-Paque 
Ficoll-Paque (Pharmacia Biotech., Asia Pacific Ltd., Hong Kong) containing 5.7 g 
Ficoll, 9 g sodium diatrizoate and calcium E D T A in 100 ml water (density = 1.077 g/ml) 
was used for in vitro isolation oflymphocytes. 
Mitogens 
Concanavalin A (Con A) from CanavaIia ensiformis and lipopolysaccharide 
(LPS) from Escherichia coli were purchased from the Sigma Chem. Co. They were 
< 
dissolved in plain R P M I medium to 500 ^ g/ml, millipore filtered and stored as 50 p,l and 
250 ^ 1 aliquots respectively at -20°C until use. 
2'Mercaptoethanol (2-ME) Solution 
0.1 M stock solution of 2-ME (Sigma Chem. Co.) was prepared in sterilized 
double distilled water and stored at -20。C until use. 
Trypan Blue Solution 
Trypan blue solution (0.4% w/v prepared in 0.817% sodium chloride and 0.06% 
dibasic potassium phosphate) was purchased from Sigma Chem. Co. 
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Neutral Red Solution 
Neutral red solution (0.5% w/v) was prepared by dissolving 0.5 g neutral red 
powder (Sigma Chem. Co.) in 100 ml normal saline. The insoluble dye was removed by 
、 
filtration through Whatman No. 1 filter paper. 
Modified Wrigh t- Giemsa Stain 
Modified Wright Giemsa stain (0.4% w/v buffered at pH 6.8 in methanol) was 
purchased from Sigma Chem. Co. 
Hematoxylin Solution 
Hematoxylin solution (Gill No. 3) was purchased from Sigma Chem. Co.. 
^ 
Wright's Stain Buffer 
Wright's stain buffer was prepared by dissolving 3.5 g KH2PO4 and 5.72 g 
N%HP04.12H20 in one litre double distilled water. The solution was adjusted to pH 7.2 
before use. 
Scintillation Fluid 
Scintillation fluid was prepared by mixing 12 g 2',5-diphenyloxazole (PPO) (Sigma 
Chem. Co.), 1.2 g 2,2'-p-phenylene-bis-[5-phenyloxazole] (POPOP) (Sigma Chem. Co.), 
2 litres toluene (Fisher Chem. Co., U.S.A.) and 1 litre Triton X-100. The mixture was 
then stirred overnight until all PP〇 and POPOP were completely dissolved, and was 
stored at room temperature in dark before use. 
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Citrate Solution 
Citrate solution containing 18 m M citric acid, 9 m M sodium citrate and 12 m M 
sodium chloride was prepared and stored at 4°C until use. 
V 
Citrate-Acetone-Formaldehyde (CAF) Solution 
CAF solution was prepared by mixing 25 ml citrate solution, 65 ml acetone and 8 
ml 37% formaldehyde together and stored at 4°C before use. 
Mitomycin C 
Mitomycin C (Sigma Chem. Co.) was dissolved in PBS as 500 ^g/ml stock 
solution and sterilized by filtration through a 0.22 |im millipore filter. The stock solution 
was stored as 100 ^ 1 aliquots in the dark at —20。C until use. 
< 
FITC-conjugated latex beads 
Fluroresbrite™ plain Y G 2 ^iM microsphere latex beads were purchased from 
Polyscience Inc. (U.S.A.) and stored in the dark at 4。C until use. 
NonidetP-40 (NP-40) Lysis Buffer 
NP-40 lysis buffer was prepared in 50 m M Tris [hydroxylmethyl] amino methane 
(Tris)-HCl, pH 7.5 containing 5 % NP-40 non-ionic detergent (Sigma Chem. Co.) and 20 
m M E D T A (Sigma Chem. Co.). 
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Tris-HCl Buffer, pH 7.5 
Tris [hydroxylmethyl] amino methane (Sigma Chem. Co.) was prepared as 1 M 
stock solution in double distilled water. The buffer was adjusted to pH 7.5 with 
、 
hydrochloric acid (HC1) and then autoclaved at 12TC for 15 min. 
TjoEojBuffer 
T,oEo.,Buffer contained 10 m M Tris-HCl (pH 7.5) and 0.1 m M EDTA. 
Propidium Iodide (PI) DNA Staining Solution 
The PI D N A staining solution was freshly prepared in PBS containing 50 ^g/ml 
PI (Sigma Chem. Co.), 400 p,g/ml ribonuclease A (RNase A) (Boehringer Mannheim), 
0.1% Triton X-100 (Sigma Chem. Co.), 10 m M E D T A with pH 7.4 (Sigma Chem. Co.) 
< 
and 0.1% trisodium citric acid (Sigma Chem. Co.). The staining solution was pre-chilled 
in dark at 4。C before use. 
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2.1.7 Reagents for Gel Electrophoresis 
Gel Loading Solution 
, 
The gel loading solution was supplied by Sigma Chem. Co. as a 5X solution of 
%. 
0.05% (w/v) bromophenol blue, 40% (w/v) sucrose, 0.1 M E D T A (pH 8.0) and 0.5% 
sodium dodecyl sulfate (SDS). It is suitable for non-denaturing agarose gel 
electrophoresis of nucleic acids. 
Tris-Borate-EDTA (TBE) Electrophoresis Buffer (5X) 
5X T B E stock was prepared by dissolving 54 g Tris，27.5 g boric acid and 20 ml 
0.5 M E D T A in 1000 ml double distilled water. The pH of the buffer was adjusted to 8.0. 
Agarose Gel 
2 % agarose gel was prepared by dissolving 20 g agarose (Sigma Chem. Co.) in 1 
litre IX T B E buffer by heating at 70。C. The solidifed agarose gel was boiled and melted 
in a microwave oven before use each time. 
Ethidium Bromide (EtBr) 
A stock solution (10 mg/ml) of ethidium bromide (Sigma Chem. Co.) was 
prepared by dissolving EtBr in double distilled water. The solution was kept at room 
temperature in dark until use. 
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2.1.8 Radioisotopes 
[methyl-'H]Thymidine fH-TdR) 
3H-TdR with specific activity of 2 Ci/mmol was purchased from Amersham Life 
%. 
Science Ltd. (U.K.). The stock solution was diluted with complete RPMI medium to 25 
p,Ci/ml working solution. For cell labelling, 20 jid working solution was added to each 
well of the 96-well flat-bottomed microtiter plate. 
Chromium-51 
Sodium chromate fNa^'CrO4) in sterilized saline solution with specific activity of 
200-500 mCi/mg chromium was purchased from Amersham Life Science Ltd. The stock 
was diluted with plain RPMI medium to 5 mCi/ml and stored at 4°C before use. 
X 
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2.2 METHODS 
2.2.1. Isolation, Purification and Characterization of Green Tea Catechins and 
Epicatechin Isomers 
、 
2.2.1.1 Extraction of Green Tea Catechins 
Total green tea catechins (GTCs) were isolated from Chinese green tea Ji Pin 
Long Jing purchased from local markets by the methods as described previously 
(Agarwal et a/.,.1992; Chen et al., 1996). Briefly, 10 g of tea leaves were extracted three 
times with 140 ml hot double distilled water at 80°C. The solution was then allowed to 
cool to room temperature, filtered and then extracted with an equal volume of chloroform 
to remove caffeine and pigments. The aqueous layer was extracted twice with an equal 
volume of ethyl acetate. The ethyl acetate phase containing green tea catechins was 
collected and the ethyl acetate was then removed with a rotary evaporator under vacuum. 
The resulting crude G T C extracts were dissolved in 10 ml double distilled water and 
freeze-dried overnight. 
2.2.1.2 Analysis of Epicatechin Isomers by HPLC 
The individual epicatechin isomers in G T C extracts were further separated and 
quantitiated by an Alltech Model 525 HPLC (Deerfield, IL, USA) as described previously 
(Chen et al., 1996). Ten microlitres G T C (2 mg/ml) extracts was injected onto the column 
(Microsorb M V , 250 x 4.6 m m , 5 ^ iM, Rainin, Woburn, M A , USA) via a rheodyne valve 
(20 p,l capacity, Alltech, Deerfield, IL, USA). A gradient of methanol in water was used 
to elute the isomers at a flow rate of 0.7 ml/min (0-7 min, methanol changed from 28% to 
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40%; 7-14 min, 40% methanol changed to 52%; 14-20 min, methanol changed from 52% 
to 28%). The separated epicatechin isomers were then monitored using an evaporative 
light scattering detector (Model M K III，Burtonsville, M D , U S A ) and a SP 4600 
、 
integrator. 
2.2.1.3 Determination of the Bio-Toxicity of Green Tea Catechins 
The bio-toxicity of G T C was determined by the brine shrimp bioassay as 
described previously (Meyer et al., 1982; McLaughlin et al., 1993). 
Shrimp Hatching 
Brine shrimp eggs were hatched in a hatching tank containing artificial sea water 
which was prepared by dissolving 3.8 g sea salt in 100 ml double distilled water. The 
< 
hatching tank was divided into two compartments by a plastic divider with small space 
away from bottom. The brine shrimp eggs were added to the covered compartment, while 
the other was illuminated. After 48 h, the mature nauplii were attracted to the illuminated 
side by phototropic movement, and were collected from the illuminated compartment. 
Brine Shrimp Bioassay 
Ten brine shrimps were placed into a vial containing 5 ml artificial sea water with 
various concentrations of GTCs (1000 ^ g/ml, 100 jig/ml and 10 p-g/ml). After 24 h, the 
number of survivors was counted and recorded, which was in tum analyzed by a 
computer software called Finney for the determination of LC50 value. LC50 is defined as 
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the concentration of the sample (^g/ml) which causes 50% death of the total shrimps. In 
this assay, hippuric acid was used as the positive control and each concentration of GTCs 
was repeated in triplicate. 
%. 
2.2,1.4 Assay ofIn Vitro Cytotoxicity of Green Tea Catechins on Splenocytes 
Murine splenocytes (5 x 10^  cells/well) were cultured with different 
concentrations of G T C in 96-well flat-bottomed microtiter plates (Coming) in a total 
volume of 0.2 ml complete RPMI medium. The cytotoxicity of G T C on splenocytes was 
determined, after incubation at 37°C in a humidified atmosphere containing 5 % C02-95% 
air for 6 h and 24 h respectively, using the trypan blue dye exclusion method (Philip, 
1973) by counting the number of dead cells in a total of 200 cells. Results were expressed 
as arithmetic mean of percentage of cytotoxicity 土 S.E. of triplicate cultures. The 
< 
percentage of cytotoxicity was calculated as follows: 
% of cytotoxicity = (number of dead cells/number of total cells) x 100% 
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2.2.2 Assays for the Immunomodulatory Activities of Green Tea Catechins 
2,2.2.1 Isolation and Preparation of Cells 
Splenocytes 
、 
Mice were firstly sacrificed by cervical dislocation and the spleens were removed 
aseptically. The spleens were then minced with a pair of scissors and pressed through a 
sterilized 60 mesh stainless steel screen into plain RPMI medium with the plunger of a 
plastic 2.5 ml syringe. The cell suspension was washed once with plain RPMI medium by 
centrifugation at 300 x g for 5 min and the splenic lymphocytes were obtained by 
gradient centrifugation (1300 x g, 30 min) with Ficoll-Paque. The lymphocytes were then 
washed twice with plain RPMI medium and resuspended in complete RPMI medium to 
appropriate cell density. 
^ 
Peritoneal Exudate Cells (PEC) 
BALB/c mice were sacrificed by cervical dislocation and placed ventral side up 
on a clean surface. The skin of the abdomen was cleaned with 70% ethanol, cut and 
pulled apart so that the abdominal wall was exposed. 5 ml cold HBSS was injected into 
the abdominal cavity using a 5 ml syringe fitted with a 18-gauge needle. The PEC were 
obtained by 2 times lavage of the peritoneal cavity, followed by 2 times washing with 
cold plain RPMI medium. The cells were finally resuspended in complete RPMI medium 
for further use. 
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2.2.2.2 In Vitro Lymphocyte Transformation Assay 
Murine splenocytes (5 x 10^) were cultured with various concentrations of G T C 
alone or in the presence of mitogens (Con A or LPS) in 96-well flat-bottomed microtiter 
气 
plates in a total volume of 0.2 ml. The cultures were incubated at 37°C in a humidified 
atmosphere containing 5 % C02-95% air. After 48 h, the cells were pulsed with 0.5 ^ Ci 
3H-TdR in a volume of 20 |il for each well for further 6 h. The cultures were then 
harvested onto a microfibre filter (Skatron instruments Ltd.) with a semi-automatic cell 
multi-harvester (Skatron instruments Ltd.) and the radioactivity was measured using a 
Beckman liquid scintillation counter LS-6700SC (Beckman Instruments, Inc.). Results in 
terms of ^ H-TdR incorporation into the cells were expressed as the arithmetic mean of 
counts per minute (cpm) 土 S.E. of quadruplicate cultures. 
< 
2.2.2.3 Mixed Lymphocyte Culture 
Generation of allogeneic stimulator cells 
C57BL/6J lymphocytes at a density of 5 x 10^ cells/ml were incubated with 25 ^ g 
mitomycin C per ml of cell suspension for 30 min at 37。C with occasional shaking. The 
cells were then washed twice with plain RPMI medium and resuspended in complete 
RPMI medium. Having treated with mitomycin C, the C57BL/67 lymphocytes were 
inhibited to proliferate in response to allogeneic stimulation. They were used as 
allogeneic stimulator cells in the mixed lymphocyte reaction using BALB/c lymphocytes 
as the responder cells. 
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Mixed lymphocyte culture 
Mitomycin C-treated C57BL/6J lymphocytes (5 x 10^) were co-cultured with an 
equal number of BALB/c lymphocytes in a total volume of 0.2 ml. The culture was 
、 
allowed to incubate at 37。C in a humidified atmosphere with 5 % C02-95% O〗.After 
72 h, the cells were pulsed with 0.5 ^ Ci ^ H-TdR in 20 jjJ volume for 20 h. The culture 
was then harvested onto a microfibre filter by a cell harvester and the incorporation of ^ -
TdR into cells was determined by a liquid scintillation counter. Results were expressed as 
the arithmetic mean of cpm 土 S.E. of quadruplicate cultures. 
2.2.2,4 Colorimetric Assay of Alloreactive Cytotoxic TLymphocytes 
The activity of alloreactive cytotoxic T lymphocytes was measured by the 
colorimetric method as described previously (Mullbacher et al., 1984). On day 1, 
< 
BALB/c mice were immunized i.p. with 1 x 10^ mitomycin C-treated L929 cells in 0.5 ml 
complete RPMI medium. On day 5, L929 cells (4 x 10^ ) in 0.1 ml were seeded into each 
well of a 96-well flat-bottomed microtitier plate at 37°C ovemight. On day 6, splenic 
lymphocytes were isolated and used as a primary source of alloreactive cytotoxic T 
lymphocytes. The BALB/c splenic lymphocytes (2 x 10^) were mixed with L929 cells so 
that the effector to target cell ratio was 50:1. After 24 h incubation at 37°C, the 
cytotoxicity of the alloreactive cytotoxic T lymphocytes was measured by neutral red 
uptake method. Briefly, the cell mixture was washed twice gently with warm PBS. 100 |Lil 
of 0.5% (w/v) neutral red solution in normal saline was added to each well, and the 
mixtures were allowed to incubate at 37°C for 30 min. Excess neutral red was then 
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washed away twice with warm PBS. Finally, 0.1 ml 1% SDS was added to each well and 
mixed with continuous shaking in a Titertek® plate shaker (Flow Lab., U.K.) until all the 
dye was completely dissolved. The absorbance in each well was measured at 540 nm 
«•. 
using a Bio-Rad microplate reader 3550 (Bio-Rad Lab., U.S.A.). The results were 
expressed as the % cytotoxicity on L929 cells which was calculated as follows: 
% cytotoxicity on L929 target = C - T x 100% 
C 
where C represents the absorbance of control wells containing no effector cells and T is 
the absorbance of test cultures containing effector cells. In this case, the absorbance of 
target cells with medium alone represents 0 % cell lysis. 
2.2.2.5 Footpad Swelling Assay of Delayed-type Hypersensitivity 
Delayed-type hypersensitivity was measured by footpad swelling method as 
described previously (Leung et al., 1986) with slight modification. BALB/c mice in 
groups of four were given i.p. injection of either PBS or GTCs (40 mg/kg) two days 
before intravenous sensitization with 10^ sheep red blood cells (SRBC) in 0.2 ml PBS. 
Four days after antigen sensitization, each mouse was challenged with 10^ SRBC in 50 ^ 1 
PBS by subcutaneous injection into the right hind footpad. The same volume ofPBS was 
injected into the left hind footpad as a control. Footpad thickness was measured at 24, 48 
and 72 h after antigen challenge and results were expressed as the mean % increase in 
footpad thickness which was calculated as follows: 
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% increase = right footpad thickness after antigen challenge- left footpad thickness after injection o f P B S x 100% 
in foodpad mean hind footpad thickness before antigen sensitization 
thickness 
2.2.2.6 Haemagglutination Assay ofIn Vivo Antibody Formation 
^ 
BALB/c mice in groups of four were given i.p. injection ofPBS or GTCs (10 and 
40 mg/kg) on day 1, 2, 4, 5. On day 3, all mice were immunized i.v. with 4 x 10^ SRBC 
in 0.2 ml PBS. On day 10 and day 17, sera of mice were collected and inactivated by 
heating at 56。C for 30 min to remove non-specific inhibitors. Serial 2-fold dilutions of the 
immune sera were made with PBS in 96-well round-bottomed microtiter plates in a final 
volume of 50 ^ 1. The same volume of 0.5% (v/v) SRBC was then added to each well. The 
plates were allowed to stand at room temperature for at least 2 h and the endpoints of 
haemagglutination were recorded afterwards. The titre of the serum was expressed as the 
reciprocal of the highest dilution of the serum which gave a positive result of 
< 
haemagglutination. 
2.2.2.7 Characterization of the Lymphocyte Subpopulations from Spleen by Flow 
Cytometry 
Splenocytes (3 x 10^) were firstly washed once with the FACS washing buffer 
containing 2 % HI-FCS and 0.05% sodium azide in PBS in order to inhibit the 
internalization of membrane components or antigen-antibody complexes. The cells were 
then incubated with 10 ^ g/ml mouse IgG and rat IgG blocking antibodies (Sigma Chem. 
Co.) at 4。C for 30 min to prevent the non-specific binding of antibody to cell surface Fc 
receptors. The cells were washed once with the FACS washing buffer and incubated with 
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1 jig monoclonal antibody against the T cell antigen (CD3) or 1:10,000 dilution of 
monoclonal antibody against the B cell antigen (LR-1) in a total volume of 100 ^1 for 
another 30 min at 4°C. Unbound antibodies were removed by washing the cells twice 
气 
with the FACS washing buffer. The cells were then stained with 1 ^ g FITC-conjugated 
goat anti-rat IgG antibody or FITC-conjugated mouse anti-rat IgM antibody respectively 
at 4®C in dark for 30 min. Afterwards, the cells were washed three times with the FACS 
washing buffer followed by fixation with 1% paraformaldehyde (w/v) in 0.85% normal 
saline. Stained cells (1 x 10^) were analyzed for fluorescence intensity by the FACSort 
flow cytometer (Becton Dickinson Immunocytometry Systems, U.S.A.) equipped with an 
argon laser with excitation wavelength of 488 nm. Data acquistion and analysis were 
performed with the Lysys II software (Becton Dickinson Immunocytometry Systems) 
(Leung etaL, 1994). 
"<r 
2.2.2.8 In Vivo Migration of Macrophages 
The in vivo macrophage migration was measured by the method as described 
previously (Gervais et al., 1984). Briefly, BALB/c mice in groups of three were either 
pre-treated with PBS or GTCs (80 mg/kg) by i.p. injection on day 1. On day 3, the mice 
were injected i.p. with 2 ml 10% protease peptone or PBS. On day 6，the elicited total and 
plastic-adherent PEC were counted as described previously (Mak et al., 1982). 
5]_  
Chapter 2 Materials and Methods 
2.2.2.9 In Vitro Assay of Phagocytic Activity of PEC 
The phagocytic activity of peritoneal macrophages was measured by the method 
as described previously (Suzuki et aL, 1988; Uff et al., 1993) with slight modification. 3 
%. 
X lC)5 PEC were seeded into each well of a 96-well flat-bottomed microtiter plate in a 
total volume of 0.1 ml R P M I medium supplemented with 10% HI-FCS. After 3 h 
incubation at 37。C，the cells were washed twice with warm plain R P M I medium to 
remove any non-adherent cells. The adherent cells were then incubated with FITC-
conjugated latex so that the latex to cell ratio was 30:1. After 1 h incubation at 37。C, the 
adherent cells were washed twice with warm PBS to remove any non-phagocytized latex 
particles. The adherent cells were then solubilized by addition of 0.1 ml 0.1% SDS. The 
uptake of latex by PEC was determined by measuring the cell-associated fluorescence 
with the CytoFluor 2350 scanner (PerSeptive Biosystems) at excitation wavelength of 
^ 
485 n m and an emission wavelength of 530 nm. On the other hand, the protein content of 
each well was determined by the Bradford method. Results were expressed as arithmetic 
mean of fluorescence per ^ g protein 土 S.E. of quadruplicate wells. 
2.2.2.10 In Vitro Assay of Macroph age-Mediated Cytostatic Activity 
On day 1, each BALB/c mouse was injected i.p. with freshly prepared picolinic 
acid solution (PLA, 100 mg/kg). On day 4, the PEC were harvested with H B S S followed 
by two times washing with cold plain RPMI medium. The cells were then resuspended in 
complete R P M I medium at 3.5 x 10^ cells/ml, and 0.1 ml cell suspension was added into 
each well of a flat-bottomed 96-well micortiter plate. After 3 h incubation at 37。C, non-
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adherent cells were removed by two times washing with warm plain RPMI medium. The 
adherent PEC (effector cells) were then incubated with 1 x 10^ MBL-2 cells (target cells) 
and 2 ng/ml LPS with or without GTCs in a total volume of 0.2 ml, so that the ratio of 
X 
effector to target cells was 35:1. The cultures were allowed to incubate at 37°C in a 
humidified atmosphere containing 5%-95% air for 48 h, followed by 6 h pulsing with 0.5 
p,Ci 3H-TdR before harvest onto a microfibre filter. The incorporation of ^ - T d R into 
cells was determined by a Beckman liquid scintillation counter. Results were expressed 
as the percentage cytostatic activity of MBL-2 induced by the activated macrophages 
which was calculated as follows: 
3H-TdR incorporation ofMBL-2 cells 
in the presence of macrophages — _ 
% Cytostatic activity 二 U x 100% 
3H-TdR incorporation ofMBL-2 cells 
in the absence of macrophages 
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2.2.3 Assays for the Anti-Tumour Activities of Green Tea Catechins 
2,2.3,1 Assay of In Vivo A n ti-tumo ur A ctivity 
On day 1, 2, 3, 4, BALB/c mice in groups of six were injected with 80 mg/kg 
、 
GTCs. Control mice were injected with an equal volume ofPBS. On day 3, all mice were 
inoculated i.p. with 1 x 10^ transplantable tumour cells , such as WEHI-3B JCS and E A T 
cells, in a total volume of 0.4 ml. All mice were sacrificed on day 10, and the tumour 
cells were harvested from the peritoneal cavity of individual mouse with ice cold PBS. 
The number of viable tumour cells was determined by counting with a hemacytometer, 
using the trypan blue dye exclusion method (Philip, 1973). 
2.23,2 Induction and Assay of Natural Killer (NK) Cell Activity 
For induction of N K activity in vivo, BALB/c mice in groups of three were < 
injected i.v. with 80 mg/kg GTCs in 0.2 ml volume. Control mice were treated with the 
same volume of PBS. After 24 h, splenic effector cells were harvested and assayed for 
N K activity by a ^ 'Cr-release assay, as previously described (Leung and Ada, 1981). The 
splenic effector cells were first suspended in the RPMI medium supplemented with 10% 
HI-FCS, whereas the NK-sensitive YAC-1 target cells were labelled with 1 mCi 
Na^'CrO4 per 1 X 10^ cells for 1 h at 37。C with gentlly shaking. Various numbers of 
effector cells were then mixed with 2 x 10^ labelled target cells in each well of the flat-
bottomed 96 microtiter plate in a final volume of 0.2 ml, and the cultures were incubated 
for 6 hr at 37。C in a humidified atmosphere containing 5%-95% air. After incubation the 
cell-free supernatant was collected. The radioactivity in 0.1 ml supernatant was measured 
60 
Chapter 2 Materials and Methods 
by a gamma counter. For spontaneous lysis, 0.1 ml 10% HI-FCS RPMI medium was 
mixed with 0.1 ml labelled YAC-1 targets. For maximum releasable ^ 'Cr, 0.1 ml Triton 
X®-100 was added to the target cells. Experimental results were expressed as the mean 
、. 
percentage specific lysis of quadruplicate wells and was calculated as follows: 
cpm^ - cpni3 
% specific lysis = ( ) x 100% 
cpm,, - cpni3 
where cpm^ is the mean cpm released in the presence of effector cells, cpm3 is the mean 
cpm released spontaneously by the target cells, and cpm,^ is the mean of the maximum 
releasable ^ 'Cr from the target cells. 
^ 
2.2.3.3 Induction andAssay of Lymphokine-activated Killer (LAK) Cell Activity 
A modification of the colorimetric assay (Mullbacher et al., 1984) was used to 
determine the lymphokine-activated killer (LAK) cell-mediated cytotoxicity. WEHI-164 
cells, which are known to be LAK-sensitive but NK-resistant, were used as the target 
cells. Effector cells were generated by co-incubating viable BALB/c lymphocytes (1 x 
10' cells/ml) with GTCs (50 ng/ml) and/or murine recombinant IL-2 (50 U/ml) at 37。C in 
10 ml complete RPMI medium for 3 days. WEHI-164 cells (3 x 10^) were seeded into 
each well of a flat-bottomed 96 well microtiter plate and incubated at 37。C ovemight. The 
medium was removed and the cells were washed twice with warm RPMI medium. 
Effector cells (1.5 x 10^) were added to the target cells in a total volume of 0.2 ml RPMI 
61 
Chapter 2 Materials and Methods 
medium supplemented with 10% HF-FCS, so that the effector to target ratio was 50: 1. 
After 24 h incubation at 37。C, the cell mixtures were washed twice with warm RPMI 
medium, followed by staining with 0.1 ml neutral red solution (0.5% in normal saline) at 
、 
37°C for 45 min. Excess neutral red was then washed away twice with warm PBS. The 
cells were lysed with 0.1 ml 1% SDS and mixed thoroughly until all the dye was 
completely dissolved. The dye uptake by the target cells was determined by measuring 
the absorbance at 540 n m using a Bio-Rad microplate reader. The results were expressed 
as the percentage cytotoxicity on WEHI-164 cells which was calculated as follows: 
C - T 
% cytotoxicity on WEHI-164 cells = ( ) x 100% 
C 
< 
where C represents mean O.D.540 of control (without effector cells added) and T 
represents mean O.D.540 of test culture (with effector cells added). 
2,2.3,4 Assay of In Vitro Tumour Cell Proliferation 
Different tumour cell lines at their exponential growth phase were seeded with 
appropriate cell numbers into each well of the flat-bottomed 96-well microtiter plates in a 
final volume of 0.2 ml complete RPMI medium in the absence or presence of different 
concentrations of the purified epicatechin isomers. After incubating at 37°C in a 
humidified atmosphere containing 5%-95% air for 48 h, the cells in each well were 
pulsed with 0.5 [xCi ^ - T d R in a volume of 20 ^1 for further 8 h before being harvested. 
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The radioactivity was measured using a Beckman liquid scintillation counter, and the 
results were expressed as the percentage of inhibition ^H-TdR incorporation, using 
untreated tumour cells as a control (Leung et al., 1994). 
%. 
2.2.3.5 In Vitro Tumour Clonogenicity Assay 
The in vitro tumour clonogenicity assay was performed in a similar way as 
described previously (Leung et cd., 1994). Briefly, semi-solid agar cell cultures were set 
up in the wells of leucocyte migration plates. Cultures (0.4 ml) containing 0.33% Bacto 
agar, appropriate numbers of tumour cells, plain RPMI medium, 20% FCS and 1% PSF 
were incubated in a humidified atmosphere containing 5 % C02-95% air. The cell 
colonies were preserved as described previously (Leung et al,, 1994). Colonies containing 
more than 50 cells were counted 7-10 days after incubation. Results were expressed as 
< 
mean 土 S.E. of triplicate cultures. 
2.2.3.6 Induction of Myleoid Leukemic Cell Differentiation 
In the experiments of induction of leukemic cell differentiation, the myeloid 
leukemia WEHI-3B JCS cells (1 x 10' cells/ml) and HL-60 cells (5 x 10' cells/ml) were 
allowed to incubate with appropriate concentrations of green tea epicatechin isomer 
E G C G at 37°C in a humidified atmosphere containing 5%-95% air for 3 days and 4 days 
respectively. The treated cells were assayed for acquisition of differentiation-associated 
characteristics as follows: 
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2,2.3.6J Assessment of Cell Morphology 
The morphological changes of cells were examined by cytocentrifuge 
preparations. The EGCG-treated cells (5 x 10^) were fixed on a microscopic slide by 
、 
cytocentrifugation at 500 rpm for 5 min using the Shandon Cytospin 3 centrifuge (Shadon 
Scientific Ltd., U.K.). Cells were stained with the modified Wright-Giemsa stain for 3 
min, then rinsed in Wright's staining buffer for 1 min followed by rinsing with running 
tap water. The air-dried slides were mounted with the neutral mounting medium, Canada 
Balsam (Beijing Chem. Works). 
2,2,3.6,2 Assay of Endocytic Activity 
Endocytic activity was determined by the uptake of fluorescein isothiocyanate 
(FITC)- conjugated bovine serum albumin (FITC-BSA) (Sigma Chem. Co.). 0.1 ml 
^ 
FITC-BSA (1 mg/ml in RPMI medium supplemented with 10% HI-FCS) was added to 
0.9 ml cell suspension (5 x lCP cells) and allowed to incubate for 6 h at 37°C in dark. The 
cell mixture was then washed three times with plain RPMI medium followed by fixing 
with 1% paraformaldehyde. Fixed cells (1 x 10^ cells) were analyzed for fluorescence 
intensity using the FACSort flow cytometer as mentioned before. 
2,2.3.7 DNA Fragmentation A nalysis 
The qualitative analysis of D N A fragmentation, a characteristic feature of 
apoptosis, was performed by a rapid and simple method as described by Herrmann et al., 
1994 with some modifications. Leukemia cells (1 x 10^) were incubated with appropriate 
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concentrations of E G C G in 150 cm^ culture flask at 37。C in a humidified atmosphere 
containing 5%-95% air for different periods of time (2, 4, 8, 12 and 24 h). The cells 
without any treatment acted as a control. The harvested cells were washed once with cold 
^. 
PBS and the cell pellets were then treated with 5 % NP-40 lysis buffer at 37。C for 10 min. 
After centrifugation at 3500 rpm for 5 min with the IEC MicroMax Eppendorf centrifuge, 
the supematants were collected and mixed with 5 % SDS. The supernatants were further 
treated with 0.4 ^ig/ml RNase A (Sigma Chem. Co.) at 56。C for 1.5 h, followed by 
ovemight treatment with 1.5 ^ g/ml proteinase K (Sigma Chem. Co.) at 56。C. The D N A 
was then precipitated with 0.1 volume of 3 M sodium acetate (Sigma Chem. Co.) and 2.5 
volume of absolute ethanoL After centrifugation at 13500 rpm for 30 min, the D N A 
pellets were washed with 70% ethanol and then absolute ethanol followed by vacuum 
drying with a speed vacuum concentrator (Savant 110 Speed-Vac®). The dried pellets 
< 
were resuspended in 20 ^ il T,oEo , buffer and stored at 4°C before gel electrophoresis. 
Before gel electrophoresis, the resuspended D N A was incubated at 65。C for 5 
min. The D N A was loaded together with IX gel loading buffer and subjected to 
electrophoresis in IX TBE electrophoresis buffer on 2 % agarose gel at a constant voltage 
of 5 volts/cm for 3-4 h. 1 ^ ig of 100 bp D N A ladder (GIBCO B R L Life Technologies 
Inc.) was loaded as a size marker. After electrophoresis, the gel was stained with 0.5 
^g/ml ethidium bromide in IX TBE buffer for 30 min followed by destaining in distilled 
water for 15 min. The stained gel was visualized under short-wavelength ultraviolet 
illumination and photographed with red filter using Polaroid Type 667 instant pack film. 
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2.2.3.8 Cell Cycle/DNA Content Evaluation 
The cellular D N A content, cell cycle frequency distributions and chromosome 
profiles of leukemia cells were analyzed by flow cytometry as described previously 
(Crissman and Hirons, 1994). The treated cells (1 x 10^ ) were harvested, washed once 
with cold PBS, and fixed with 1 ml 70% ethanol at 4°C for 30 min. The fixed cells were 
washed twice with cold PBS to remove the ethanol, and then stained with 1 ml PI D N A 
staining solution in dark for 1.5 h at room temperature. The cells stained with PI (1 x 10, 
were analyzed for fluorescence intensity using the FACSort flow cytometer as described 
in Section 2.2.2.7. Data acquisition was performed with Lysys II software whereas the 
calculation of cell cycle distribution was performed with CellFIT program using the 
rectangle fit (RFIT) analysis model (Becton Dickinson Immunocytometry Systems) 
(Brons etal., 1994). 
< 
2.2.3.9 Statistical A nalysis 
In most cases, each experiment was performed at least twice and the results of 
only one representative experiment were presented. The data were expressed as arithmetic 
mean 土 standard error. Statistical analysis was performed using the Student's 't' test with 
a confidence interval set at 95% for group comparisons. Normally p < 0.05 was regarded 
as significantly different. 
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3.1 Introduction 
Epidemiological studies from around the world have constantly reported that diet 
with high intake ofbioactive phytochemicals from plants is associated with low incidence 
of many types of cancer. Tea is derived from the leaves of Camellia sinensis, an 
% 
evergreen shrub in the family of Theaceae. It is one of the most popular beverages 
consumed worldwide. Tea contains a rich source of phytochemicals including the tea 
polyphenols. The benefits of drinking tea for prevention of cancer were indicated from a 
number of experimental and clinical studies fNCI, D C P C Chemoprevention Branch and 
Agent Development Committee, 1996). Experimental studies demonstrating the cancer 
chemopreventive effects of tea have been conducted mainly with green tea (Katiyar et al., 
1996). Green tea is the non-fermented tea which is widely consumed in Asian countries, 
especially in China and Japan. The major constituents of green tea are flavan-3-ol or 
green tea catechins (GTCs), which may constitute up to 30% of the dry leaf weight (Yang 
et al., 1993). From a variety of in vitro and in vivo experimental studies, green tea 
catechins were shown to have potent anti-carcinogenic activities (Yang and Wang, 1993; 
Katiyar and Mukhtar, 1996). 
In recent years, there has been an increasing interest in the study of various 
beneficial effects of green tea. Apart from the well-documented anti-oxidative and anti-
carcinogenic activities, green tea has been found to have a wide range of pharmacological 
activities, including anti-mutagenic, anti-fungal, anti-bacterial, anti-viral, and 
hypolipidemic activities (Dreosti, 1996). In addition, green tea and its catechin 
constituents were also found to have anti-inflammatory (Chan et al., 1996; Matsuo et aL, 
1996), anti-allergic (Shiozaki et al., 1997), and immunomodulatory activities (Sakagami 
et al., 1992; Hu et aL, 1993). Despite these studies, the active components responsible for 
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these diverse beneficial effects and the underlying mechanisms involved remain largely 
unclear. Since the isolation and purification of green tea catechins are quite simple and 
well established (Agarwal et al., 1992; Chen and Chan, 1996), and a number of 
preclinical safety studies have shown that green tea and its catechin constituents were 
、 relatively non-toxic fNCI, D C P C Chemopreventive Branch and Agent Development 
Committee, 1996), therefore, they represent good candidates for further studies of their 
immunomodulatory and anti-tumour properties. In this chapter, the extraction, 
purification and analysis of green tea catechins from the Chinese green tea, Ji Pin Long 
Jing, were described. Attempts had been made to determine the bio-toxicity and cellular 
toxicity using simple assays. 
< 
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3.2 Results 
3.2.1 Extraction of Catechins from the Chinese Green Tea, Ji Pin Long Jing 
Tea leaves from the Chinese green tea, Ji Pin Long Jing, were extracted with hot 
water for three times. Then the extract was allowed to cool, filtered and then extracted 
场. 
with chloroform. The aqueous layer was further extracted with ethyl acetate in which the 
green tea catechins were collected. The ethyl acetate was then removed by evaporation 
under vacuum. The yield of GTCs extract was about 7-8% (w/w) of dried Jin Pin Long 
Jing tea leaves from three determinations. 
3.2.2 Analysis of Epicatechin Isomers by HPLC 
The individual epicatechin isomers in the GTCs extracts were separated using 
HPLC, and then monitored using evaporative light scattering detector and integrator. 
Individual epicatechin isomers were identified by comparing the retention time of known 
standards or adding kno^^n standards to the sample. Table 3.1 showed the composition of 
GTCs extracted from Jin Pin Long Jing tea. Epigallocatechin gallate (EGCG) was found 
to be the major component which accounted for 63.1% of total GTCs. This is followed by 
epicatechin gallate (ECG, 18.8%), epigallocatechin (EGC, 6.4%), and epicatechin (EC, 
2.8%). 
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Table 3.1 Composition of GTCs Extracted from the Chinese Green Tea Ji Pin Long 
Jing 
Epicatechin Isomer Relative amount (% total GTCs) 
Epicatechin (EC) 2.80±0.07 
、 Epicatechin gallate (ECG) 18.76 土 0.49 
Epigallocatechin (EGC) 6.44 土 0.25 
Epigallocatechin gallate (EGCG) 63.09 土 0.15 
Others 8.92±0.35 
The individual epicatechin isomers in the GTCs extracts were separated using HPLC. 
The separated epicatechin isomers were monitored using an evaporative light scattering 
detector and an integrator. Individual epicatechin isomers were identified by comparing 
the retention time of known standards or adding known standards to the sample. Results 
were expressed as mean 土 S.E. of triplicate determinations. 
•c 
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3.2.3 Bio-toxicity Determination by Brine Shrimp Bioassay 
The brine shrimp bioassay is a simple, economic and reliable bioassay which is 
commonly used for determining the bio-toxicity of natural products in vivo (Anderson et 
al., 1991). As shown in Table 3.2, The LC50 value of green tea catechins determined by 
、 brine shrimp bioassay was found to be greater than 1 mg/ml, indicating that the green tea 
catechins have no apparent toxicity to animals. 
Table 3.2 Determination of the Bio-toxicity of GTCs by Brine Shrimp Assay 
Treatment LC50 (^g/ml) 
Hippuric acid 340 
GTCs > 1000* 
Ten brine shrimps (Artemia salina LEACH) were mixed with different concentrations of 
GTCs (10, 100，and 1000 ^ ig/ml) in a total volume of 5 ml. The number of survivors were 
counted and recorded after 24 h. The bio-toxicity represented as LC50 value was 
determined. LC50 is defined as the concentration of sample (p,g/ml) which causes 50% 
death of the total shrimps in the brine medium. Hippuric acid was used in this assay as a 
positive control. 
*LC50 value greater than 1000 ^g/ml indicates that the tested sample has no apparent 
toxic effect. 
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3.2.4 Effect ofGTCs on the Viability ofMurine Splenocytes 
GTCs were tested for their cytotoxicity on murine splenocytes in vitro. Murine 
splenocytes (5 x 10^ cells) were incubated with various concentrations of GTCs in a total 
volume of 0.2 ml at 37°C. The number of dead cells was determined at 6 h and 24 h of 
“ incubation by the trypan blue dye exclusion method. The results in Table 3.3' showed that 
GTCs did not exhibit any apparent cytotoxicity to murine splenocytes in vitro at 
concentrations up to 102.4 |iig/ml, and the difference of the percentage cytotoxicity 
between the control group (PBS-treated) and the treatment group (GTCs-treated) was 
found to be less than 6 % at all the concentrations tested. 
< 
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Table 3.3 In Vitro Cytotoxicity of GTCs on Murine Splenocytes 
Concentration of GTCs % of cytotoxicity* 
(^g/ml) 6li 2 4 l 
0 6.83 ±3.44 10.25 ±0.75 
’ 0.1 8 . 2 1 士 1 . 1 2 1 5 . 8 3 ± 0 . 9 3 
0 . 4 8 . 1 7 ± 0 . 1 7 1 4 . 6 7 士 1 . 6 7 
1.6 1 2 . 2 5土 1.25 16.32±0.51 
6.4 8.83± 1.45 14.83 ±0.88 
2 5 . 6 8.00± 1 . 0 4 1 5 . 6 7 土 1 . 4 5 
51:2 6.70 ±0.60 12.17±1.17 
1 0 2 . 4 9 . 3 3 ± 1 . 3 6 1 2 . 6 7土 0 . 4 4 
Splenocytes were incubated with various concentrations of GTCs at 37°C. After 6 h and 
24 h respectively, 200 cells were counted using a hemacytometer by the trypan blue dye 
exclusion method. 
^ 
* % of cytotoxicity = (number of dead cells / number of total cells ) x 100% 
Results were expressed as arithmetic mean 土 S.E. of triplicate cultures. 
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3.3 Discussion 
In the present study, Jin Pin Long Jing tea, one of the most popular Chinese green 
tea consumed in China, was used as a source of GTCs. Methods of extracting GTCs were 
well established. Although the total amount of extractable GTCs varied with different 
、 
varieties of tea, the age of tea leaves, and the extraction methods employed, the yield of 
GTCs extracted by the present method was about 7-8% by weight of the dried tea leaves, 
which was in agreement with the yield of 5.8 — 9.6% as reported in the literature 
(Graham, 1992; Hara, 1994). The composition of the epicatechin isomers was also 
relatively consistent when compared with that of other studies (Graham, 1992; Hara, 
1994). The most abundant one was E G C G , followed by E C G , E G C and EC. 
Green tea and its catechins constituents have long been investigated for their various 
pharmacological activities using different animal models. Results from various in vivo 
toxicological studies indicate that green tea, GTCs and the epicatechin isomers are non-
toxic to animals (NCI, D C P C Chemoprevention Branch and Agent Development 
Committee, 1996). In the present study, the bio-toxicity of GTCs was determined by a 
simple, economic and convenient brine shrimp bioassay (Meyer et al., 1982; McLaughlin 
et aL, 1993), and no toxic effect was found. Besides, GTCs were also found to have little, 
if any, cytotoxicity towards murine splenocytes. 
In view of their various pharmacological activities with potential therapeutic values, 
together with the ease of extraction and non-toxic in nature as determined in this chapter, 
GTCs are worthy of further investigation for their immunomodulatory and anti-tumour 
activities as will be reported in the following chapters (Chapter 4 and 5). 
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4.1 Introduction 
The immune system can be modified by diet, pharmacologic agents, 
environmental pollutants, and naturally occurring food chemicals. Flavonoids, a large 
group of low molecular weight polyphenolic secondary plant metabolites which are 
^. 
important to the health and maintenance of herbivorous animals including humans, 
have been found to possess diverse effects on the functions of different cell types 
involved in immunity and inflammation (Middleton and Kandaswami, 1992). Some 
flavonoids have inhibitory effects on the immune function especially at high 
concentrations. It was reported that a number of plant polyphenols inhibited the 
proliferation and IL-2 production ofhuman lymphocytes (Atlum et al, 1991; Devi and 
Das, 1993). A recent study also demonstrated that polyphenols in chocolate (CLP) 
inhibited R O S production by granulocytes and lymphocytes, mitogen-induced 
proliferation of T cells, polyclonal Ig production by B cells and inhibited both IL-2 
m R N A expression of arfd IL-2 secretion by T cells (Sanbongi et al., 1997). On the 
other hand, some flavonoids have been found to be immunostimulatory. Flavone 
acetic acid, for instance, was shown to augment murine N K cell activity in vivo 
(Homung etaL, 1988). 
Tea is a popular beverage derived from the plant Camellia sinensis. In Asia, 
drinking tea especially green tea has traditionally been regarded as a generally healthy 
practice. Green tea is a rich source of flavan-3-ols (catechins) which are commonly 
categorized as minor flavonoids. These components have been found to possess 
diverse biological effects such as anti-oxidative (Chen and Chan, 1997), anti-
microbial (Okubo et al, 1991; Ikigai et al., 1993; Nakayama et aL, 1994)， 
hypolipidemic (Hara, 1992), anti-mutagenic and anti-carcinogenic activities (Yang 
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and Wang, 1993; Katiyar and Mukhtar, 1996). However, until recent years, the 
immunomodulatory activity of green tea catechins still has not been well elucidated 
and documented. More recently, tea extracts and their catechins were reported to 
inhibit type-I hypersensitivity reaction (Shiozaki et al., 1997) and have inhibitory 
%. 
effects on inflammatory responses of immune cells (Chan et al,, 1996; Matsuo et al., 
1996; Lin and Lin, 1997). On the contrary, some experimental studies showed that the 
catechins have stimulatory effects on the proliferation and functions of the immune 
cells (Ikeda et al., 1984; Sakagami et aL, 1992; Hu et al., 1993). These findings 
concerning the immunomodulatory activities of green tea are quite inconsistent, and 
the mechanisms by which green tea catechins can exert their effects on the cells ofthe 
immune system have not been fully understood. 
In this chapter, the modulating effects of green tea catechins on both the specific 
and non-specific immune responses were investigated. The effects of green tea 
catechins on the proliferative responses and functions of lymphocytes were examined 
in vitro and in vivo. Moreover, the ability of GTCs to activate macrophages, which are 
important effector cells in non-specific immunity, was also examined. 
1_6  
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4.2 Results 
4.2.1 Effects of GTCs on the In Vitro Proliferation of Murine Splenocytes 
The mitogenic activity of GTCs was assayed by measuring the D N A synthesis of 
lymphocytes after incubating the murine splenic lymphocytes for 48 h with various 
气 
concentrations of GTCs. Results in Fig. 4.1 showed that GTCs significantly exhibited, 
albeit low, mitogenic activity on murine splenic lymphocytes. The proliferative 
response was peaked at 50 ng/mL 
4.2.2 In Vitro Co-mitogenic Effect ofGTCs on Murine Splenocytes 
Besides the mitogenic activity, GTCs were also tested for their co-mitogenic 
activity by co-culturing murine splenocytes with various concentrations of GTCs and 
mitogens (Con A as T cell mitogen; LPS as B cell mitogen) at their suboptimal and 
optimal concentrations. As shown in Fig. 4.2 and Fig. 4.3, the mitogen-induced 
lymphoproliferative responses were significantly enhanced in a dose-dependent 
manner. Similar to the mitogenic effect, it was found that maximal co-mitogenic 
effect occurred at a G T C concentration of 50 ng/ml in the presence of optimal 
concentrations of the mitogens. However, at suboptimal concentrations of the 
mitogens, the co-mitogenic effect was observed at a lower concentration (12.5 ng/ml) 
ofGTCs (Fig. 4.2&4.3). 
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Fig. 4.1 In Vitro Mitogenic Effect of GTCs on Splenic Lymphocyte Proliferation. 
BALB/c splenocytes (5 x 10^ cells/well) were incubated with various concentrations 
ofGTCs (0 — 200 ng/ml) in a total volume of0.2 ml. After 48 h ofculture at 3TC, the 
o 
cells were pulsed with H-TdR (0.5 ^ iCi/20 ^il) for 6 h before harvest. Radioactivity in 
counts per minute (cpm) was measured using a liquid scintillation counter. Each point 
represents the mean cpm 土 standard error (S.E.) of quadruplicate cultures. 
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Fig. 4.2 In Vitro Co-mitogenic Effect of GTCs on Con A-induced Splenocyte 
Proliferation. Splenocytes (5 x 10^ cells/well) were incubated with various 
concentrations of GTCs (0 — 200 ng/ml) in the presence of Con A at pre-determined 
suboptimal (0.5 p.g/ml) and optimal (1.5 ^ g/ml) concentrations in a total volume of 
0.2 ml. After 48 h ofculture, the cells were pulsed with ^ - T d R (0.5 ^ iCi/20 ^il) for 
6 h before harvest. Radioactivity in counts per minute (cpm) was measured using a 
liquid scintillation counter. Each point represents the mean cpm 土 S.E. of 
quadruplicate cultures. 
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Fig. 4.3 In Vitro Co-mitogenic Effect of GTCs on LPS-induced SpIenocyte 
Proliferation. Splenocytes (5 x 10^ cells/well) were incubated with various 
concentrations of GTCs (0 - 200 ng/ml) in the presence of LPS at pre-determined 
suboptimal (1 ^ g/ml) and optimal (10 ^ ig/ml) concentrations in a total volume of 0.2 
ml. After 48 h of culture, the cells were pulsed with ^ - T d R (0.5 ^ Ci/20 jil) for 6 h 
before harvest. Radioactivity in counts per minute (cpm) was measured using a liquid 
scintillation counter. Each point represents the mean cpm 土 S.E. of quadruplicate 
cultures. 
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4.2.3 Stimulation of Lymphocyte Proliferation In Vitro by Intraperitoneal 
Administration of GTCs 
Having shown the mitogenic activity of GTCs in vitro, the in vivo effect of GTCs 
on lymphocytes proliferation was also investigated. Splenocytes from mice pretreated 
、 
for 4 days with various doses of GTCs were cultured alone or in the presence of 
mitogens. It was found that i.p. injection of GTCs at a dose of 10 mg/kg caused a very 
slight enhancement of lymphocyte proliferation in vitro. However, no stimulatory 
effect was observed at other doses of GTCs (Fig. 4.4). The in vivo stimulatory effect 
was also observed when the lymphocytes from GTCs-treated mice were cultured with 
mitogens. Fig. 4.5 and Fig. 4.6 showed that the Con A-or LPS-induced proliferation 
of the splenocytes from GTCs-treated mice was significantly enhanced, but the 
optimal doses were different for each mitogen. This indicates that the pretreatment of 
mice with GTCs may have a stimulatory effect on different populations of 
lymphocytes in vivo. ^ 
4.2.4 Effect of In Vivo Treatment of GTCs on In Vitro Mixed Lymphocyte 
Reaction 
Apart from the mitogenic and co-mitogenic activities as shown before, the effect 
of GTCs administration on allogeneic stimulation of lymphocytes was also 
investigated in a one-way mixed lymphocyte culture (MLC) using mitomycin C-
treated C57BL/6J splenocytes as stimulators. As shown in Fig. 4.7，the proliferative 
response of BALB/c lymphocytes from the mice pretreated with GTCs (5-20 mg/kg) 
to allogeneic C57BL/6J lymphocytes was significantly enhanced compared to that 
pretreated with PBS only. This result confirms our previous findings that 
administration of GTCs into mice causes significant enhancement of lymphocyte 
m  
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proliferation in vitro. 
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Fig. 4.4 Effect of In Vivo Administration of GTCs on Lymphocyte Proliferation 
In Vitro. BALB/c mice in groups of three were injected i.p. with various doses of 
GTCs from day 1 to day 4. On day 5, splenocytes were harvested and cultured at a 
density 5 x 10^ cells/well at 37°C. After 72 h of incubation, the cells were pulsed with 
^H-TdR (0.5 jaCi/20 i^l) for 20 h before harvest. Radioactivity incorporated was 
measured and the results were expressed as the mean cpm 土 S.E. of quadruplicate 
cultures. The differences between the PBS-treated group and GTCs-treated groups 
were determined by Student's Mest. *p < 0.05. 
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Fig. 4.5 Effect ofIn Vivo Administration ofGTCs on Con A-induced Lymphocyte 
Proliferation In Vitro. BALB/c mice in groups of three were injected i.p. with 
various doses of GTCs from day 1 to day 4. On day 5, splenocytes were harvested and 
cultured at a density 5 x 10^ cells/well in the presence of Con A at pre-determined 
suboptimal (0.5 ^ g/ml) and optimal (1.5 ^ g/ml) concentrations. After 48 h incubation 
at 37°C, the cells were pulsed with ^ - T d R (0.5 ^ iCi/20 fil) for 6 h before harvest. 
Radioactivity incorporated was measured and the results were expressed as the mean 
cpm 士 S.E. of quadruplicate cultures. The differences between the PBS-treated group 
and GTCs-treated groups were determined by Student's r-test. *p < 0.01, **p < 0.05, 
***;7<0.002. 
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Fig. 4.6 Stimulatory Effect ofIn Vivo Administration of GTCs on LPS-induced 
Lymphocyte Proliferation In Vitro. BALB/c mice in groups of three were injected 
i.p. with various doses of GTCs from day 1 to day 4. On day 5，splenocytes were 
harvested and cultured at a density 5 x 10^ cells/well in the presence of LPS at pre-
determined suboptimal (1 ^ g/ml) and optimal (10 ^ ig/ml) concentrations. After 48 h 
incubation at 37。C, the cells were pulsed with ^ - T d R (0.5 ^ iCi/20 |il) for 6 h before 
harvest. Radioactivity incorporated was measured and the results were expressed as 
the mean cpm 土 S.E. of quadruplicate cultures. The differences between the PBS-r ated group and GTCs-treated groups were determined by Student's r-test. *p < 0.005, *=V < 0.001, ***;? < 0.0001. ^  
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Fig. 4.7 Effect ofIn Vivo Administration of GTCs on In Vitro Mixed Lymphocyte 
Reaction. BALB/c mice in groups of three were injected i.p. with various doses of 
GTCs from day 1 to day 4. On day 5, splenic responder cells were harvested and co-
cultured at a density 5 x 10^ cells/well with equal number of allogeneic stimulator 
cells (mitomycin C-treated C57BL/6J lymphocytes). After 72 h ofincubation at 37°C, 
the cells were pulsed with ^ - T d R (0.5 |iCi/20 i^l) for 20 h before harvest. 
Radioactivity incorporated was measured and the results were expressed as the mean 
cpm 土 S.E. of quadruplicate cultures. The differences between the PBS-treated and 
GTCs-treated groups were determined by Student's r-test. ^ p < 0.05, **/? < 0.02. 
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4.2.5 Effect of In Vivo Administration of GTCs on Splenic Lymphocyte 
Subpopulations 
Results in Section 4.2.3 showed that in vivo administration of GTCs caused a 
slight enhancement of lymphocyte proliferation in vitro. Therefore, it is of interest to 
， examine whether there are any changes in lymphocyte subpopulations in splenocytes 
from GTCs-treated mice, as determined by flow cytometry using monoclonal 
antibodies to mouse T cell-specific antigen (CD3) or mouse B cell antigen (LR-1). 
However, as shown in Fig. 4.8 and 4.9, there was no significant change in the 
proportions of T and B cell subpopulations in GTCs-treated mice under the prescribed 
experimental conditions. 
4.2.6 Effect of In Vivo Administration of GTCs on the Induction of Alloreactive 
Cytotoxic T Lymphocytes In Vivo 
In view of their stimulatory effect on the proliferative response of lymphocytes, 
GTCs were investigated for their modulatory effects on the specific functions of 
lymphocytes. Since the development of alloreactive cytotoxic T lymphocytes is an 
important effector function of T lymphocytes in response to alloantigens such as 
tissue, or organ grafts，therefore, it was of interest to examine whether GTCs could 
affect the induction of alloreactive T cell response in vivo. Results in Fig. 4.10 
showed that i.p. injection of GTCs could only slightly enhance the cytotoxic activity 
of the alloreactive cytotoxic T cells and the percentage specific lysis of target cells 
from the control group (PBS-treated), and the two GTCs-treated groups (20 
mg/kg/day and 40 mg/kg/day respectively) were found to be 38.7%, 45.5% and 44.8% 
respectively. 
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Fig. 4.8 FACS Analysis of T Cell Population from Splenocytes of GTCs-treated 
Mice. Lymphocytes (5 x 10^ cells) prepared from spleen of(a) PBS-treated, (b) GTCs 
(10 mgy^g/day Lp. for 4 days)-treated, or (c) GTCs (40 mg/kg/day i.p. for 4 days)-
treated mice were stained with rat monoclonal antibody to CD-3 antigen on T cells. 
Paraformaldehyde-fixed cells (10^ cells) were analyzed for fluorescence intensity using 
the FACSort flow cytometer. Blue line represents fluorescent intensity of cells stained 
with anti-CD3 antibody. 
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Fig. 4.9 FACS Analysis of B Cell Population from Splenocytes of GTCs-treated 
Mice. Lymphocytes (5 x 10^ cells) prepared from spleen of(a) PBS-treated, (b) GTCs 
(10 mg/kg/day i.p. for 4 days)-treated, or (c) GTCs (40 mg/kg/day i.p. for 4 days)-
treated mice were stained with rat monoclonal antibody to LR-1 antigen on B cells. 
Paraformaldehyde-fDced cells (10^ cells) were analyzed for fluorescence intensity using FACS t flow cytometer. B ue line repres nts the fluorescent int nsity of cell  stained with anti-LR-1 antibody. 
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Fig. 4.10 Effect of GTCs on the In Vivo Induction of Alloreactive Cytotoxic 
Lymphocytes. On day -2, -1, 2, 3, various doses of GTCs were injected i.p. into 
groups of three BALB/c mice. On day 1, 1 x 10? mitomycin C treated L929 cells were 
injected i.p. into each mouse. On day 6, the cytotoxicity of the alloreactive T cells was 
assayed by colorimetric method. The differences between the control group and 
treatment groups were determined by Student's Mest. ^ p < 0.005, **/? < 0.01. 
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4.2.7 In Vivo Induction of Delayed Type Hypersensitivity (DTH) Response to 
Sheep Red Blood Cells (SRBC) by GTCs 
Mice are known to develop a D T H response following intravenous injection of 
sheep red blood cells (SRBC), and the maximum response is detected 4 days after 
、 antigen sensitization (Mitsuoka et al, 1978). Experiment was done to examine 
whether administration of GTCs into mice could affect their ability to develop a D T H 
response in vivo. The results from Fig. 4.11 showed that GTCs significantly enhanced 
the in vivo induction of a D T H response to SRBC when administered 2 days prior to 
antigen injection. At 24 h after SRBC antigen challenge, the percentage increase of 
footpad thickness of GTCs-treated mice was around 50%, which was over two times 
higher than that of control mice. Similar enhancement was also observed at 48 h after 
challenge. This result indicates that GTCs may enhance the activation and/or 
differentiation ofDTH T lymphocytes in vivo. 
<• 
4.2.8 Primary Humoral Immune Response to SRBC in GTCs-treated Mice 
Since GTCs were found to be mitogenic to lymphocytes, and have co-mitogenic 
effect on B-cell mitogen (LPS) induced lymphocyte proliferation, therefore, the effect 
of GTCs on the B cell response in vivo was investigated. BALB/c mice were either 
treated with GTCs (10 mg/kg and 40 mg/kg body weight injected i.p.) or PBS on day 
1, 2, 4, 5. On day 3, mice were immunized with 4 x 10^ SRBC by i.v. injection. The 
circulating haemagglutinating antibody titre was determined at 7 days and 14 days 
post-immunization. It was found that the level of circulating antibody to SRBC was 
only slightly increased (a two fold increase) at 7 days after antigen injection, but no 
increase (or even a slight decrease at a dose 40 mg/kg GTCs) was observed at 14 days 
after antigen injection (Table 4.1). This indicates GTCs may have little, if any effect  
^  
Chapter 4 The Immunomodulatory Activities of GTCs 
on the ability of mice to produce antibodies against a T-dependent antigen in vivo 




Chapter 4 .. The Immunomodulatory Activities of GTCs 
6 0 . ^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^^ 
> ^ 
mmm PBS 




^ ‘ . 
,,〈 v;v. .>C5vs<-^  ‘ 




C3 • '：〉，r 
^ �r’�,: 
8 30 - 、::?:'： 
^ :'/—): 
r2 :':;?'、、， ** 
•口 ;-,--v 
<D T 、、:>、': ‘ ；^ 
c/5 . ,: 、. '• a OA —_=:、：、:> 
0； z u - m m m >-.-；- ” 
^ ^ m ' � " : : � -
^ H 
•S • « : , T 
^ •、:;)） 丁 “ � F ^ 
1 0 - • : / :、 ;、丄 :、〜 T -
•、 : t b、 _ ' : : : ; _ ' : 7 
^^m ‘ - K"^- ^ ^ H 、、 ^ ^m 
^ • : : : : • > / . ' . : •、'、:-
^ ^ H … ^ ^ H • -'• ‘ ^ ^ H v:?"-
0 J M ^ _ _ • • 
24h 48h 72h 
Time after foodpad challenge 
Fig. 4.11 Stimulatory Effect of GTCs on DTH Response to SRBC In Vivo. 
BALB/c mice in groups of four were injected i.p. with PBS or GTCs (40 mg/kg) 
followed by immunization with 10^ S R B C by i.v. injection 2 days later. Four days 
after antigen sensitization, each mouse was challenged with 10^ S R B C in 50 |il of 
PBS injected subcutaneously into the right hind footpad, while the same volume of 
PBS was injected into the left hind footpad as a control. The increases in footpad 
thickness were measured 24 — 72 h after antigen challenge. Results were represented 
as % increase of footpad thickness 土 S.E. The differences between the control and 
treatment groups were determined by the Student's /-test. *p < 0.005, *^p < 0.00005. 
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Table 4.1 Humoral Antibody Response to SRBC in Mice Treated with GTCs 
Pre-treatment of mice with^ Serum haemagglutinating antibody titer 
7 days 14 days 
raS 640 640 
， 10 mg/kg GTCs 1280 640 
40 mg/kg GTCs 1280 320 
a BALB/c mice in groups of four were pre-treated with PBS or GTCs (10 and 40 
mg/kg injected i.p.) on day 1, 2, 4, 5. On day 3, all mice were immunized with 4 x 
10^ S R B C . . 
b The sera from mice in each group were collected and pooled together at 7 days and 
14 days post-immunization with SRBC. The haemagglutinating antibody titer was 
expressed as the reciprocal of the highest dilution of serum which gave a positive 
result of haemagglutination. 
< 
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4.2.9 Effect ofGTCs on In Vivo Migration ofMacrophages 
It has been known that i.p. administration of irritant substances such as 
thioglycollate and proteose peptone can increase the yield of macrophages in the 
peritoneal cavity of mice (Ogmundsdottir and Weir, 1980). In this experiment, the 
、 effect of GTCs treatment on the influx of macrophages alone or in response to locally 
administered sterile protease peptone in vivo was examined. The results in Table 4.2 
showed that mice treated with GTCs alone induced about two fold increase of 
adherent PEC number when compared to that of PBS-treated mice. Moreover, 
treatment of GTCs significantly augmented the protease peptone-elicited migration of 
macrophages into the peritoneal cavity in vivo. Both results illustrate that GTCs are 
potent stimulators of macrophage migration in vzvo. 
4.2.10 Effect of GTCs on the Phagocytic Activity of Thioglycollate-elicited 
Macrophages Itu Vitro 
Phagocytosis is one of the important effector functions of macrophages which 
plays an important role in the non-specific cellular defense system. This function is 
known to be modulated by exposure to antigens or biological response modifiers, and 
is generally assayed as a parameter of macrophage activation. Therefore, experiments 
were performed to study the effect of GTCs on in vitro phagocytic activity of 
thioglycollate-elicited macrophages. As shown in Fig. 4.12, pre-incubation of the 
thioglycollate-elicited macrophages with various concentrations of GTCs for 24 h at 
37°C significantly stimulated the phagocytic activity of the macrophages in a dose-
dependent manner which peaked at a concentration of 6.4 ^ g/ml. 
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Table 4.2 Effect of GTCs on the In Vivo Migration of Macrophages 
Treatment of mice^ Adherent PEC recovered 





GTCs + PP 153.8±6.9** 
a BALB/c mice in groups of three were pre-treated with PBS or GTCs (80 mg/kg) on 
day -1, followed by i.p. treatment of 1.5 ml 10% protease peptone or PBS on day 1. 
Three days later, the elicited PEC were harvested by three times lavage of the 
peritoneal cavity with cold HBSS. 
b The adherent PEC were the cells which remained attached to the plastic surface after 
incubation at 37°C for 3 h and were not removed by twice washing with warm plain 
RPMI medium. The number of adherent PEC recovered was calculated as follows: 
X 
Adherent PEC recovered 二 (Total PEC recovered - Non-adherent PEC recovered) 
Significantly different from control， p^ < 0.005，**;? < 0.0005. 
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Fig. 4.12 Effect of GTCs on the Phagocytic Activity of Thioglycollate-elicited 
Peritoneal Macrophages In Vitro. BALB/c mice were injected i.p. with 1.5 ml 3 % 
thioglycollate and 3 days later the PEC were harvested, seeded at density of 3 x 10^ 
cells/well, and incubated with various concentrations of GTCs at 3TC. After 24 h, the 
cells were washed twice with warm plain RPMI medium and then incubated with 
FITC-conjugated latex bead, so that the latex to cells ratio was 30:1. After 1 h of 
incubation at 37°C, the uptake of latex by PEC was determined by measuring the 
relative fluorescence of the cells, while the protein content was determined by 
Bradford method. Results were expressed as arithmetic mean of fluorescence per ^ g 
protein 土 S.E. of quadruplicate wells. 
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4.2.11 Effect of In Vivo Administration of GTCs on Phagocytic Activity of 
Thioglycollate-elicited Macrophages In Vitro 
Besides studying the in vitro effect of GTCs on the phagocytic activity of 
thioglycollate-elicited macrophages, the effect of in vivo administration of GTCs on 
、 such activity was also examined. It was found that pretreatment of mice with 40 
mg/kg of GTCs had a slight stimulatory effect on the phagocytic activity of TG-
elicited macrophages, but the result was not significant (Fig. 4.13). At a higher dose 
of GTCs (80 mg/kg), however, the phagocytic activity of the TG-elicited 
macrophages was similar to that ofthe control. 
4.2.12 Effect of GTCs on In Vitro Cytostatic Activity of PicoIinic Acid-activated 
Macrophages 
Normal peritoneal macrophages without any activation by macrophage activating 
factor and endotoxin generally exhibit little cytostatic activity against tumour cells. 
Previous work by Ruffmann et al. (1984) showed that i.p. injection of picolinic acid 
(PLA) into the peritoneal cavity of mice resulted in activation of the peritoneal 
macrophages which became cytostatic against MBL-2 lymphoma cells in the presence 
of nanograms ofLPS in vitro. In this experiment, whether GTCs have any modulating 
effect on the cytostatic activity of PLA-activated macrophages in vitro was 
investigated. As shown in Fig. 4.14, in vitro exposure of PLA-activated macrophages 
to GTCs significantly inhibited the growth of MBL-2 cells in a dose-dependent 
manner with maximal enhancement of cytostatic activity at a concentration of 6.4 
p,g/ml GTCs. This optimal concentration also caused maximal stimulation of the 
phagocytic activity ofTG-elicited macrophages in vitro (Fig. 4.12). 
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Fig. 4.14 Effect of GTCs on the In Vitro Cytostatic Activity of PLA-activated 
Peritoneal Macrophages. Six BALB/c mice were pre-treated with PLA (100 mg/kg 
injected i.p.) on day 1 for PEC activation. After 3 days, PEC were harvested, seeded 
at a density of3.5 x 10^ cells/well and incubated with various concentrations of GTCs 
in total volume of 0.1 ml at 3TC. After 24 h, the cells were washed twice with warm 
plain RPMI medium and then incubated with MBL-2 target cells (10^ cells/well) so 
that the effector to target cells ratio was 35:1. The cultures were allowed to incubate at 
37°C for 48 h, followed by 6 h pulsing with ^ - T d R (0.5 ^ Ci/well) before harvest. 
Radioactivity incorporated was measured and the cytostatic activity of PLA-activated 
macrophages was determined as described in Materials and Methods Section 2.2.2.10. 
The results were expressed as arithmetic mean 土 S.E. of quadruplicate wells. 
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4.2.13 Effect of In Vivo Administration of GTCs on the Cytostatic Activity of 
Picolinic Acid-activated Macrophages 
Having shown to be stimulatory on the cytostatic activity of PLA-activated 
macrophages in vitro, GTCs were also examined for their in vivo effect on 
� macrophages. BALB/c mice were pre-treated with GTCs prior to treatment with PLA, 
and the peritoneal macrophages were harvested and then assayed for the cytostatic 
activity against MBL-2 cells. Results in Fig. 4.15 showed that the PLA-activated 
macrophages obtained from GTCs-treated (40 mg/kg i.p.) mice exhibited significantly 
higher cytostatic activity on MBL-2 tumour cells as compared to the PLA-activated 
macrophages from PBS-treated mice, indicating an enhancing effect of GTCs on the 
effector function of activated macrophages. However, similar to the results of in vivo 
administration of GTCs on the phagocytic activity, a higher dose of GTCs (80 mg/kg) 
seemed to have no effect or even inhibitory effect on the effector functions of the 
activated macrophages. ^ 
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Fig. 4.15 Effect of In Vivo Administration of GTCs on Induction of Cytostatic 
Activity of PLA-activated Macrophages. BALB/c in groups of three were pre-
treated with PBS or various doses of GTCs injected i.p. on day 1. On day 3, all the 
mice were treated with picolinic acid (PLA) for macrophage activation (100 mgfkg 
given i.p.). After 3 days, the activated PEC were harvested by three times lavage of 
peritoneal cavity with cold HBSS and then resuspended in complete RPMI medium. 
PEC (3.5 X lC)5) were seeded in each well of microtiter plate and incubated at 37°C for 
3 h. After incubation, the non-adherent PEC were removed by washing with warm 
plain RPMI medium, followed by addition of target MBL-2 cells (1 x 10^) into each 
well so that the ratio of effector to target cells was 35:1. The cultures were allowed to 
incubate at 37�C for 48 h, and then pulsed with 0.5 fiCi ^ - T d R ovemight before 
harvest. Radioactivity incorporated was measured using a liquid scintillation counter. 
The cytostatic activity of the PLA-activated macrophages was determined as 
described in Materials and Methods Section 2.2.2.10. The results were expressed as 
arithmetic mean 土 S.E. of quadruplicate wells. 
* Significantly different from control, p < 0.01 
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4.3 Discussion 
Tea has been highly valued by the Chinese for its medicinal benefits. 
Traditionally, it is claimed to have beneficial effect on improving resistance to 
diseases. In recent years, numerous epidemiological studies and experimental findings 
� 
both show that tea and its active constituents catechins have promising role in 
prevention of diseases such as cardiovascular diseases and cancer. In this chapter, the 
green tea catechins were investigated for their immunomodulatory activies, as the host 
immune system has an important role in protecting the body against pathogemc 
infections and cancer. The immunostimulating effects of GTCs were firstly screened 
for the in vitro lymphocyte transformation effect which is a typical non-specific 
immune reaction and the mechanism of which has been well understood. Because of 
its high sensitivity, this assay has frequently been used as a tool to investigate 
lymphocyte responsiveness. From the results ofFig. 4.1 , GTCs were found to display 
significant, albeit low, mitogenic effect on murine splenocytes at low concentrations 
(< 0.2 p,g/ml), but the effect declined thereafter (data not shown). This result was 
consistent with the findings ofHu et al. (1993) which had also shown that the major 
green tea epicatechin isomer EGCG enhanced both spontaneous and LPS-induced 
proliferation of splenic B cells at low concentrations (0.5-10 ^ig/ml) but suppressed 
them at high concentrations (50 p,g/ml). The activation of lymphocytes by GTCs may 
be resulted from the galloyl group ofEGCG and ECG (Hu et aL, 1993). However, the 
suppression at high concentrations was unlikely to be due to direct lymphotoxicity, as 
exposure of the splenocytes to high concentrations (up to 100 p,g/ml) of GTCs did not 
lead to any significant loss of cell viability (Chapter 3). The mechanism of 
suppression of lymphocyte proliferation at high concentrations of GTCs requires 
further investigations. 
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On the other hand, GTCs could markedly enhance the lymphoproliferative 
response of murine splenocytes to T cell mitogen (Con A) and B cell mitogen (LPS), 
indicating that GTCs may play an important role in activation of both T and B cell 
populations in vitro. The in vivo experiments confirmed the stimulatory role of GTCs 
， on different target cell populations. GTCs were slightly mitogenic in vivo, and 
significantly augmented the lymphocyte blastogenesis stimulated by Con A, LPS, and 
specific alloantigen. 
Apart from the stimulatory effects of GTCs on T and B cell proliferation in vitro 
and in vivo, GTCs were examined further for their effects on T and B cell functions in 
vivo. The in vivo administration of GTCs was demonstrated to result in a significant 
stimulation of the cytotoxicity of alloreactive cytotoxic T lymphocytes. In addition, 
the in vivo generation of a DTH response against SRBC mediated by effector T cells 
were also markedly enhanced by in vivo treatment of mice with GTCs. In contrast, the 
stimulatory effect of GTCs on the B cell function was less well-defined. Our data 
showed that the primary humoral response antibody response mediated by B cells was 
only slightly enhanced by GTCs treatment. From all these findings, it can be 
concluded that GTCs can effectively enhance the specific induction of T cell 
functions in vivo. 
Besides having modulatory activities on T and B lymphocytes involved in 
specific immunity, the effects of GTCs on macrophages, which are the key players in 
non-specific immunity, were also examined. In vitro study indicated that GTCs at low 
concentrations significantly enhanced the phagocytic capacity of peritoneal 
macrophages in a dose-dependent manner, but the stimulation decreased at higher 
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concentrations. On the other hand, in vivo administration of GTCs failed to augment 
significantly the phagocytic activity of TG-elicited peritoneal macrophages in vitro. 
The other effector function of macrophages, cytostatic activity, was also examined 
and similar results were obtained both in vitro and in vivo. The stimulatory effects of 
“ GTCs on macrophages in vitro were consistent with those reported previously, in 
which the epicatechin isomers such as EGCG stimulated IL-1 production from human 
peripheral blood monocytes (Sakagami et al., 1992; Miyamoto et al., 1997). 
Interestingly, a suppressive effect of EGCG on the activity of activated macrophages 
had been reported (Chan et al., 1995; Lin and Lin, 1997). Chan et aL (1995) showed 
that the epicatechin isomer EGCG could inhibit nitric oxide fNO) production from 
LPS-activated macrophages. The inhibition of NO production in activated 
macrophages had been attributed to the inhibition of inducible nitric oxide synthase 
(iNOS) gene expression and inhibition of iNOS enzymatic activity (Chan et al., 
1997). Moreover, Lin and Lin (1997) demonstrated that EGCG blocked the activation 
of nuclear factor-KB, a transcription factor necessary for the induction of iNOS 
transcription. In addition to the effector function of macrophages, the number of 
resident peritoneal macrophages and the migration of macrophages into the peritoneal 
cavity as a result of thioglycollate-elicited acute inflammation were markedly 
enhanced by in vivo treatment of mice with GTCs. The mechanism(s) by which GTCs 
might exert such a stimulatory effect on macrophage migration in vivo remains poorly 
understood. It may be a result of increased secretion of soluble mediators by 
macrophages or increased chemotactic response of macrophages as a result of GTCs 
treatment. 
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In this chapter, GTCs were shown to have significant modulatory effects on the 
functions and activities of various non-specific and specific immune cells, including 
their ability to activate macrophages and stimulation of lymphocyte subpopulations, 
both in vitro and in vivo. It is likely that such immunomodulatory effects of GTCs 
V 
may be related to their anti-carcinogenic and anti-tumour activities. Nevertheless, 
further studies are necessary to resolve the mechanisms by which GTCs might interact 
with the cells of immune system and to define the possible mechanisms by which 
GTCs or their epicatechin isomers can exert their anti-tumour effects, both in vitro 
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5.1 Introduction 
Although the "war on cancer" as proclaimed by the U.S. President Richard M. 
Nixon has been proceeding over 25 years, cancer still represents the single largest 
cause of human death on a worldwide basis, and claims over 6 millions lives each 
气 
year today (Perzzuto, 1997). At present, the modalities used in cancer treatment in 
conventional medicine such as surgery, radiotherapy, and cytotoxic chemotherapy are 
still unsatisfactory due to their limited applications, ineffectiveness, and severe side 
effects (Boik, 1996). As a result, there has been an increasing interest in the search of 
novel anti-cancer agents from natural plant sources which are presumed to be less 
toxic in nature (Perzzuto, 1997). 
In the recent decades, the anti-cancer activities of the phytochemicals have been 
under extensive investigation. Some bioactive compounds isolated from plants 
exhibited potent anti-tumour activities which are associated with their 
immunostimulant effects (Xing and Li, 1993; Wong et al., 1994; Choy et al; 1994; 
Miyamaoto et al., 1997). On the other hand, the anti-tumour activities of some 
phytochemicals may be mediated through induction of cancer cell differentiation (Jing 
et aL, 1993; Mak et aL, 1996; Fung et aL, 1997), induction of apoptosis (Traganos et 
al., 1992; Spinozzi et aL, 1994; Wei et aL, 1994), and inhibition of angiogenesis, 
invasion as well as metastasis (Taniguchi et al； 1992; Fotsis et al., 1993; Makimura et 
al., 1993). 
Green tea catechins (GTCs), a type of flavonoids isolated from green tea leaves, 
have been studied in details for their preventive role in carcinogenesis (Yang and 
Wang, 1993; Katiyar and Mukhtar, 1996; Dreosti, 1996; Dreosti et aL, 1997). 
107 
Chapter 5 The Anti-tumour Activities ofGTCs 
However, there are very few studies on the direct anti-tumour activities of GTCs. Lea 
et al (1993) reported that green tea polyphenol (GTP) and EGCG could strongly 
inhibit the DNA synthesis of rat hepatoma HTC cells and mouse erythroleukemia 
DS19 cells in vitro, but exhibited only marginal effect on the differentiation ofDS19 
� 
cells. More recently, green tea catechins were also found to be capable of inhibiting 
the proliferation of human tumour cells in vitro (Valcic et al., 1996; Yang et al., 
1998). The inhibitory effect of green tea catechins on the growth of established 
tumours in vivo has also been reported. For examples, Wang et al. (1992) 
demonstrated that GTP or EGCG given intraperitonealy (i.p.) inhibited the growth 
and caused partial regression of established skin papilloma in CD-1 mice. On the 
other hand, Liao et al. (1995) showed that i.p. injection of EGCG but not ECG 
inhibited the growth ofhuman prostate and breast tumour cells in athymic nude mice. 
Although evidence has been accumulated showing that green tea catechins can inhibit 
the growth of tumour cells, both in vitro and in vivo, however, the precise mechanisms 
by which green tea catechins can exert their effects on the tumour cells and the 
relationship between their chemical structures and anti-tumour activity remain poorly 
understood. In the Chapter 4, the immunomodulatory activities of GTCs had been 
examined both in vitro and in vivo. In this chapter, the in vitro and in vivo anti-tumour 
activities, as well as the underlying mechanisms, such as stimulation of immune 
effector cells and induction of tumour cell differentiation and apoptosis, will also be 
examined. 
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5.2 Results 
5.2.1 Effect ofGTCs on the Growth ofTransplantable Tumour Cells In Vivo 
The in vivo anti-tumour activity of GTCs was studied using two murine 
transplantable tumour cell lines, WEHI-3B JCS and EAT in BALB/c mice. As 
� . 
illustrated in Fig. 5.1 and 5.2, the i.p. injection of GTCs at a dosage of 80 mg/kg for 
four consecutive days significantly suppressed the growth of two transplantable 
tumours in vivo, was found to significantly suppressed the growth of tumors in vivo, 
with 37.4 % suppression for the myeloid leukemia JCS cells and 41.6 % suppression 
for the ascites carcinoma EAT cells. 
5.2.2 Effect of GTCs on In Vivo Induction ofNatural Killer (NK) Cells 
As shown in the previous experiments, GTCs were found to have an inhibitory 
effect against the growth of tumour cells in vivo. In order to determine whether the 
anti-tumour activity of GTCs might be mediated through the activation of the host's 
cytotoxic anti-tumour cells, therefore, the ability of GTCs to activate different types 
of non-specific cytotoxic cells was studied. Natural Killer fNK) cells have important 
roles in resistance to tumour and have been found to mediate cytotoxic effect against a 
variety of tumour cells (Brittenden et al., 1996). In this experiment, the effect of 
GTCs administration on induction of NK cells was examined. BALB/c mice were 
injected with GTCs (80 mg/kg injected i.v.) and the splenic NK cells were harvested 
and assayed after 24 h. As shown in Fig. 5.3, the cytolytic activity of splenocytes 
from GTCs-treated mice towards the NK-sensitive YAC-1 cells was significantly 
enhanced compared to that of the control mice, suggesting that GTCs can positively 
modulate NK activity in vivo. 
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Fig. 5.1 Effect of GTCs on the Growth of JCS Cells In Vivo. BALB/c mice in 
groups of six were injected i.p. with GTCs (80 mg/kg) for four consecutive days (day 
1-4). Control mice were injected with an equal volume of PBS. On day 3, all mice 
were injected i.p. with a syngeneic transplantable tumour - JCS (1 x 10^ cells/mouse). 
The tumour cell number recoverable from the peritoneal cavity of each mouse was 
determined on day 10. The difference between the control group and treatment group 
was determined by Student's Mest. * P < 0.01. 
110  
Chapter 5 The Anti-tumour Activities of GTCs 
1000 1  
’- 丁 
00 
T_H [ ~ ‘ n 0) 
^ 800 - .':;::::.:::::.:. 
N^^ , 
‘ � � 
H . . - ' ‘ . 
X …’::''::'’:： 
^ ^ - ^ ^ . , � ” / � ’ ’ > ' 
� ‘ ‘ ‘ , 
<D . . -• , . ./' 
I 600 - * ~^  • . , “ ^ , . . ,,„ 丨’, 
p" _H � � / 
1—^  
( D 、 ’ . -- . : • ' • ' 、 • • ‘ 
0 : - ‘ ..:. ” •-"' 
吕 4 0 0 - , 、 : 二 
o :� ,, : : : •  
S 
^"1 � � - ‘ \ , X “ 
^ ‘ 、 ’ . : ‘ , 
^ , , • . , : •---： 
o • ‘ ‘:.., 
fe 2 0 0 - \ . " ' : ' � : : . : / “ •^*•^  ‘ ‘ N - , , � f^ ‘-�‘� ‘ -‘ . ^ - - ‘ - • 
£ 、 "- " ,? ‘ ‘？ 口 • ,, ,--； ^ ^ … � : -r • ： ‘ '.: - / ' � . / 
^ -： -‘、 .,....；、“… 
、 s - - ‘‘ 
‘ ‘ 、 �V ^ � . ‘ ‘ 
0 J - ' ' '   
P B S - t r e a t e d G T C s - t r e a t e d 
( 8 0 m g / k g ) 
Fig. 5.2 Effect of GTCs on the growth of EAT cells In Vitro. BALB/c mice in 
groups of six were injected i.p. with GTCs (80 mg/kg) for four consecutive days (day 
1-4). Control mice were injected with an equal volume of PBS. On day 3, all mice 
were injected i.p. with a transplantable tumour — EAT (1 x 10^ cells/mouse). The 
tumour cell number recoverable from the peritoneal cavity of each mouse was 
determined on day 10. The difference between the control group and treatment group 
was determined by Student's Mest. * P < 0.001. 
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Fig. 5.3 Effect of GTCs on the In Vivo Induction of NK cells. On day 1, BALB/c 
mice into groups of three were injected i.v. with GTCs (80 mg/kg). Control mice were 
injected with an equal volume of PBS. Twenty-four hours later, splenic NK activity 
was assayed by a 4 hr cytotoxic assay using ^^Cr-labelled YAC-1 cells as target at 
effector-to-target ratios of 25:1, 50:1 and 100:1. Results were expressed as mean % 
specific lysis 士 S.E. of quadruplicate cultures. The differences between the treatment 
groups and the corresponding control groups were determined by Student's r-test. * P 
< 0.01, ** P < 0.005, and *** P < 0.0005. 
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5.2.3 Effect of GTCs on In Vltro Induction of Lymphokine-activated Killer 
(LAK) Cell Activity 
LAK cells activity, which can be generated by incubating mouse splenocytes 
with IL-2, is able to lyse fresh tumour target cells and autologous tumour cells. The 
LAK cells activity can be generated from a variety of mouse strains and are active 
against a broad range of mouse tumours, both in vitro and in vivo. To examine 
whether GTCs have a modulating effect on LAK activity, a modified colorimetric 
assay was used to determine the LAK cell-mediated cytotoxicity using WEHI-164 as 
the target cells. It was found that the cytotoxicity against WEHI-164 cells induced by 
incubation of splenocytes with GTCs (50 ng/ml) alone was much higher than the 
control, and the extent of the cytotoxicity was comparable to that generated by 
incubation of splenocytes with IL-2 (Fig. 5.4), indicating that GTCs alone can induce 
LAK-like activity in vitro. On the other hand, co-incubation of GTCs and IL-2 
together with splenocytes further enhanced the cytotoxicity, although the extent of 
enhancement was not very large. This indicates that GTCs may have an additive 
effect rather than a synergistic effect on the LAK activity generated by IL-2. 
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Fig. 5.4 Effect of GTCs on the In Vitro Induction of LAK Activity by GTCs. 
BALB/c normal spleen cells C^SC) (1 x 10? cells/ml) were co-incubated with GTCs 
(50 ng/ml) and/or murine rmIL-2 (50 U/ml) in 10 ml complete RPMI medium for 3 
days at 37�C. Effector cells (1 x 10^  cells/0.1 ml) were added to the target (WEHI-
164) cells so that the E/T ratio was 50:1. After 24 h incubation period at 37°C, the cell 
mixtures were washed and stained with neutral red. The uptake by target cells was 
determined by measuring the absorbance at 540 nm after lysing the cells in 1% SDS 
solution. The results were expressed as the % cytotoxicity 土 S.E. of quadruplicate 
cultures. The differences between the control group and treatment groups were 
determined by the Student's t test. * P < 0.02, ** P < 0.005, and *** P < 0.0005. 
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5.2.4 In Vitro Cytotoxicity of Green Tea Epicatechin Isomers on Murine and 
Human Tumour Cell Lines 
Apart from studying the in vivo anti-tumour activity of GTCs, the direct anti-
tumour activity of GTCs was investigated using the purified epicatechin isomers. First 
’ of all, the cytotoxicity of different green tea epicatechin isomers ECG, EGCG, EGC 
and EC on the murine myeloid leukemia JCS cells was determined by trypan blue 
exclusion assay after 48 hours of incubation. From the results shown in Fig. 5.5, only 
EGCG and EGC exhibited significant cytotoxic effect on JCS cells when their 
concentrations were higher than 25 p,M and 30 p,M respectively. ECG and EC, 
however, did not show any cytotoxic effect at a concentration up to 35 ^M. The 
differential cytotoxic effects of various epicatechin isomers on JCS cells are in the 
descending order ofEGCG > EGC > ECG > EC. 
The most potent epicatechin isomer EGCG was further investigated for its 
cytotoxicity on another murine myeloid leukemia cell line Ml, and a human myeloid 
leukemia cell line HL-60 (Fig. 5.6). It was found that different myeloid leukemic cell 
lines had different sensitivity to EGCG (Fig. 5.6). The murine myelomonocytic 
leukemia JCS cells were the most sensitive whereas the human promyelocytic 
leukemia HL-60 cells were the least sensitive to the cytotoxic effect ofEGCG. 
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Fig. 5.5 Differential Cytotoxic Effect of Green Tea Epicatechin Isomers on JCS 
Cells. Murine myeloid leukemia WEHI-3B JCS cells were incubated with various 
concentrations (0 — 35 i^M) of different epicatechin isomers at 37°C for 48 h. Cell 
viability was determined by trypan blue exclusion test, and the results were expressed 
as % mean of viable cells 土 S.E. of triplicate cultures.  
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Fig. 5.6 Differential Cytotoxic Effect of EGCG on Various Myeloid Leukemia 
Cell Lines. Murine myeloid leukemia WEHI-3B JCS cells and Ml cells, and human 
myeloid leukemia HL-60 cells were incubated with various concentrations (0 - 35 
j_iM) of EGCG at 37�C for 48 h. Cell viability was determined by trypan blue 
exclusion test, and the results were expressed as % mean of viable cells 土 S.E. of 
triplicate cultures. 
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5.2.5 In Vitro Cytostatic Effect ofEGCG on Various Tumour Cell Lines 
In the previous section, GTCs had been shown to be inhibitory against the 
growth of tumours in vivo. In the present study, the growth-inhibitory activities of 
different green tea epicatechin isomers ECG, EGCG, EGC and EC on the myeloid 
， leukemia JCS cells cultured in vitro were examined by using the ^H-TdR 
incorporation assay. Fig. 5.7 showed that only EGCG and EGC could exhibit 
significant anti-proliferative effect on JCS cells when their concentrations were higher 
than 20 p,M. ECG and EC, however, only exhibited weak anti-proliferative effect, 
even at a concentration of up to 35 ^M. The differential anti-proliferative effects of 
various epicatechin isomers on JCS cells are in the descending order ofEGCG > EGC 
> ECG > EC. 
Besides being the major component of GTCs, EGCG was shown to be the most 
potent epicatechin isomer in inhibiting the growth of leukemia JCS. Therefore, it was 
chosen to be further investigated for its inhibitory effect on a panel of tumour cell 
lines. Various tumour cell lines with appropriate cell densities were incubated with 
different concentrations of EGCG for 48 h, and the cell proliferation was measured by 
o 
the H-TdR incorporation assay. The tumour cell lines under study included myeloid 
tumours (Fig. 5.8), macrophage-like tumours (Fig. 5.9), lymphoid tumours (Fig. 
5.10), fibroblast-like tumours (Fig. 5.11) and a carcinoma cell line EAT (Fig. 5.12). It 
was found that the growth of different tumour cell lines was all inhibited by EGCG in 
a dose dependent manner, but the sensitivity was different. Table 5.1 summarized the 
values of 50% inhibitory concentration (IC50) and maximal inhibitory concentration 
ofEGCG on different tumour cell lines. It can be seen that the most sensitive tumour 
cell lines are the HL-60 and YAC-1 cells, whereas the most resistant tumour cell lines 
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Fig. 5.7 Differential Anti-proliferative Effect of Green Tea Epicatechin Isomers 
on JCS Cells. Murine myeloid leukemia WEHI-3B JCS cells were incubated with 
various concentrations (0 — 35 p.M) of different epicatechin isomers at 37°C for 48 h. 
Cultures were then pulsed with 0.5 jiiCi of ^H-TdR for 8 hr before harvest. 
Radioactivity in cpm was measured using the liquid scintillation counter. Results were 
expressed as % inhibition of ^H-TdR incorporation, using the untreated cells as a 
control. Each point represents the mean 土 S.E. of quadruplicate cultures. 
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Fig. 5.8 Effect of EGCG on the Proliferation of Myeloid Leukemia Cells (JCS, 
M l and HL-60). JCS cells (2 x 10^  cells/0.2 ml), Ml cells (5 x 10^  cells/0.2 ml) and 
HL-60 cells (1 x 10^ cells/0.2 ml) were incubated with different concentrations (0 -35 
i^M) of EGCG at 37�C for 48 h. Cultures were then pulsed with 0.5 ^Ci of ^ - T d R 
for 8 h before harvest. Radioactivity in cpm was measured using the liquid 
scintillation counter. Results were expressed as % inhibition of ^H-TdR incorporation, 
using the untreated cells as a control. Each point represents the mean 土 S.E. of 
quadruplicate cultures. 
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Fig. 5.9 Effect of EGCG on the Proliferation of Macrophage-like Tumour Cells 
(PU5-1.8 and P388D1). PU5-1.8 and P388D1 cells (1 x 10^ cells/0.2 ml) were 
incubated with different concentrations of EGCG (0 -35 i^M) at 37°C for 48 h. 
Cultures were then pulsed with 0.5 i^Ci of ^H-TdR for 8 h before harvest. 
Radioactivity in cpm was measured using the liquid scintillation counter. Results were 
’ 
expressed as % inhibition of ^H-TdR incorporation, using the untreated cells as a 
control. Each point represents the mean 土 S.E. of quadruplicate cultures. 
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Fig. 5.10 Effect ofEGCG on the Proliferation ofLymphoid Tumour Cells (MBL-
2 and YAC-1). MBL-2 and YAC-1 cells (5 x 10^  cells/0.2 ml) were incubated with 
different concentrations (0 -35 ^M) of EGCG at 37�C for 48 h. Cultures were then 
pulsed with 0.5 p,Ci of ^H-TdR for 8 h before harvest. Radioactivity in cpm was 
measured using the liquid scintillation counter. Results were expressed as % inhibition 
of ^H-TdR incorporation, using the untreated cells as a control. Each point represents 
the mean 土 S.E. of quadruplicate cultures. 
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Fig. 5.11 Effect of EGCG on the Proliferation of Fibroblast-Iike Tumour Cells 
CWEHI-164 and L929). WEHI-164 cells (5 x 10^  cells/0.2 ml) were incubated with 
different concentrations (0 -35 i^M) of EGCG at 37^C for 48 h. Cultures were then 
pulsed with 0.5 jaCi of ^H-TdR for 8 h before harvest. Radioactivity in cpm was 
measured using the liquid scintillation counter. Results were expressed as % inhibition 
of ^H-TdR incorporation, using the untreated cells as a control. Each point represents 
the mean 土 S.E. of quadruplicate cultures. 
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Fig. 5.12 Effect ofEGCG on the Proliferation ofMouse Carcinoma Cells (EAT). 
EAT (5 X 10^  cells/0.2 ml) were incubated with different concentrations (0 -35 p,M) 
ofEGCG at 37°C for 48 h. Cultures were then pulsed with 0.5 i^Ci o f ^ - T d R for 8 h 
before harvest. Radioactivity in cpm was measured using the liquid scintillation 
counter. Results were expressed as % inhibition of ^H-TdR incorporation, using the 
untreated cells as a control. Each point represents the mean 土 S.E. of quadruplicate 
cultures. 
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Table 5.1 The IC50 Values and Maximal Inhibitory Concentrations of EGCG on 
Different Tumour Cell Lines 
ip-"-^-^  - ‘ ••_•• • ‘ -'• ” ‘ •-'-•• ‘ ‘ ---• rr- - r•;-.Ts-..-i: • • I I I ‘ -Tf ;rrf".rBr- •‘ 丨-i-_ • •‘••…•,-•• =；•• ‘！"•!_•=• a.•• t..••丨,• •.;！:• ； ,'.r.rsm-r.i:•••:_ •,丨丨• ‘ i 
Tumor ceIl lines IC50 vaIue* Maximal inhibitory 
concentration^ 
(网 
( ^ M ) 
^ Myeloid tumours WEHI-3B JCS 14 25 
Ml 25 35 
HL-60 4 20 
Macrophage-like PU5-1.8 > 3 5 > 3 5 
tumours  
P388D1 > 35 > 35 
Lymphoid tumours MBL-2 24 30 
YAC-1 5 15 
Fibroblast-Iike WEHI-164 23 30 
tumours  
L929 35 > 35 
Mouse carcinoma EAT 27 35 
丨  
* ICso value is the conc"entration of EGCG required for 50% inhibition of ^H-TdR 
incorporation. 
丑 • • 
Maximal Inhibitory concentration is the concentration of EGCG in which the 
inhibition reaches a plateau. 
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5.2.6 Effect ofEGCG on the In Vitro Clonogenicity ofMyeloid Leukemia Cells 
Besides the anti-proliferative effect on tumour cells, EGCG was further 
examined for its effect on the clonogenicity of myeloid leukemia cells in vitro. 
Leukemia cell lines (JCS and HL-60) with appropriate cell numbers were plated in 
， soft agar cultures with various concentrations ofEGCG, and colonies were counted at 
least 7 days later. Results in Table 5.2 and 5.3 showed that the capacity of EGCG-
treated cells to form colonies was significantly reduced in a dose-dependent manner. 
The cloning efficiency of JCS cells was reduced from 18.67% without treatment to 
2.34% at 20 p,M EGCG, whereas that of HL-60 cells was reduced from 23.40% 
without treatment to 1.97% at 15 jiM EGCG. 
X 
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Table 5.2 Effect ofEGCG on the Clonogenicity ofJCS Cells In Vitro 
~ C o n c . ofEGCG (|iM) No. of colonies in % cloning efficiency 
soft agar 
0 37.33 i4 .33 18.67 t2 .17 
10 36.67 ±4.70 18.34 ±2.35 
% 
15 17± 3.79 8.5 ±1.90* 
20 4.67± 1.45 2.34 ±0.73** 
JCS cells (200 cells per well) were incubated with different concentrations (0 — 20 
^M) ofEGCG at 37^C for 7 days. After hematoxylin staining, the number of colonies 
containing more than 50 cells was counted. Results were expressed as no. ofcolonies 
and % cloning efficiency in soft agar 士 triplicate cultures. % cloning efficiency 
represents the number of colonies/100 cells plated in soft agar cultures. 
Significantly different from untreated cells: *p < 0.05; **/? < 0.005 
•K 
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Table 5.3 Effect ofEGCG on the Clonogenicity ofHL-60 Cells In Vitro 
Conc. ofEGCG (^iM) No. of colonies in % cloning efficiency 
soft agar 
0~ 234±4.04 23.40±0.40 
5 198.67 士9.70 19.87±0.97 
I 
10 32.67±7.31 3.27±0.73* 
15 19.67土 1.20 1.97±0.12* 
HL-60 cells (1000 cells per well) were incubated with different concentrations (0 - 15 
|j,M) of EGCG at 37°C for 10 days. After hematoxylin staining, the number of 
colonies containing more than 50 cells was counted. Results were expressed as no. of 
colonies and % cloning efficiency in soft agar 土 triplicate cultures. % cloning 
efficiency represents the number of colonies/100 cells plated in soft agar cultures. 
Significantly different from untreated cells: * p < 0.005 
X 
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5.2.7 Induction of Apoptosis of the Myeloid Leukemia HL-60 Cells by EGCG In 
Vitro 
DNA fragmentation is one of the characteristic of apoptosis which involves the 
activation of Ca�+, Mg2+-dependent endonuclease(s). The resulting oligonucleosomal 
， DNA fragments are multiple of approximately 180-200 bp and can be resolved as a 
characteristic “DNA ladder" by a qualitative analysis performed by conventional 
agarose gel electrophoresis (Herrmann et aL, 1994; Columbano, 1995). 
In recent years, the anti-tumour mechanism of new compounds derived from 
natural products has been intensively investigated, and many of them are found to be 
able to inhibit tumour cell growth by apoptosis (Yanagihara et aL, 1993; Achiwa et 
al., 1997; Ahmad et al., 1997; Okabe et al., 1997). In Section 5.2.5, we have shown 
that among the three myeloid leukemia cell lines tested, the human promyelocytic 
leukemia, HL-60, was found to be the most sensitive to the anti-proliferative effect of 
EGCG. Therefore, in the present study, EGCG was examined for its ability to induce 
apoptosis in HL-60 cells. 
The effect of EGCG on the induction of apoptotic DNA fragmentation in HL-60 
cells was shown in Fig. 5.13. The fragmented DNA was found to occur at 2 hours 
after the cells were treated with 15 ^M EGCG, and the amounts increased to a 
maximal as the incubation time was prolonged to 12 hours. 
The induction of apoptosis was also indicated by the flow cytometric analysis of 
cell cycle kinetics in EGCG-treated cells. As shown in Fig. 5.14, the small peak found 
in front of the Go/Gi peak of the cell cycle profile indicated the presence of the 
m  
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fragmented DNA resulted from apoptosis. 
Cells undergoing apoptosis also display profound structural changes including a 
rapid blebbing of the plasma membrane and nuclear disintegration, which can be 
气 
monitored on cytocentrifuge preparation. The nuclei of HL-60 cells treated with 
EGCG (15 ^iM) were clearly found to be fragmented with condensed chromatin, both 
of which are signs of apoptosis (Fig. 5.15). 
5.2.8 Effect ofEGCG on the Cell Cycle Kinetics of the Myeloid Leukemia HL-60 
Cells In Vitro 
Since the induction of apoptosis may be mediated through the regulation of cell 
cycle, the effect of EGCG on cell cycle perturbations of the HL-60 cells at different 
periods of time was also examined by flow cytometry. It was found that the EGCG-
treatment resulted in an<appreciable arrest of the HL-60 cells in Go/Gi phase of the 
cell cycle as the percentage of cells in the Go/Gi phase showed a proportional increase 
with the incubation time up to 12 hours (Fig. 5.14 and Table 5.4). This increase in 
Go/Gi population was accompanied with a decrease of cell number in S phase. The 
G2 + M population, on the contrary, did not show any significant and consistent 
change and in fact a slight decrease was observed. 
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Fig. 5.13 Effect of EGCG on the Induction of DNA Fragmentation in HL-60 
Cells. HL-60 cells (1 x 10^ cells) were incubated with EGCG (15 ^iM) at 37°C for 
different periods of time (from 2 to 24 h). Apoptotic DNA fragments were isolated by 
the mild detergent NP-40 (5%) lysis buffer, and were analyzed by electrophoresis on 
2% agarose gel stained with ethidium-bromide. 
Lane 1: 100 bp DNA ladder Lane 5: 12 h treatment 
Lane 2: 2 h treatment Lane 6: 24 h treatment 
Lane 3: 4 h treatment Lane 7: 24 h control (without treatment) 
Lane 4: 8 h treatment 
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Fig. 5.14 Effect ofEGCG on the Cell Cycle Profile in HL-60 Cells. HL-60 cells (5 
X lC)4 cells/ml) were incubated with EGCG (15 i^M) at 37°C for different periods of 
time (2 to 24 h). EGCG-treated cells (1 x 10^ cells) were fixed with ethanol and 
stained with PI under hypotonic conditions. PI-stained cells were analyzed for 
fluorescence intensity using FACSort flow cytometer. Cell cycle distribution was 
calculated by the CELLFIT program using RFIT analysis model. 
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Fig. 5.15 Effect of E C C G on Induction o f A p o p t o s i s o f H L - 6 0 cells. 
HL-60 cells (1 x 10^  cells) wcrc incubalcd (a) with control medium or (b) with HGCG 
(15 pM), at 370 for 4 h. The morphological changes of cells were e>:amined by 
c>locentrifuge preparations as described in Materials and Methods Section 2.2.3.6.1. 
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Table 5.4 Effect ofEGCG on the Cell Cycle Distribution ofHL-60 Cells 
Incubation time “ % of Cells _ = ~ _ | 
with 20 i^M EGCG ~~Go/Gi phase~~ S phase ~~G2 + M phase~~ 
2 h 48.7 35.9 15.4 
4 h 542 K O r O 
、 ^ 65^ 0 ^ 0 
I T h 6 Z 8 ^ 2 9 : 0 
2 4 l 5Z0 ^~~404 Te  
Untreated control 44.3 38.7 17.0 
; ^ S 2 S 5 3 S S S S S ^ = S 3 ^ ; S = S S S S = S = ; = i = = ^ = = = i t = ^ = = = ^ = = ^ ^ = = ^ = = : = ^ = = = i ^ ^ = = ^ = = = = = ^ = = = = ^ ^ = = ^ = = = = ^ = = = = = = ^ 
HL-60 cells (5.x 10^ cells/ml) were incubated with 15 |iM EGCG at 37°C for different 
periods of time. The DNA was stained with propidium iodide and the fluorescence 
intensity was analyzed with a flow cytometer. The percentage of cells at different 
phases ofthe cell cycle was calculated by the CELLFIT program, using the rectangle 
fit (RJFIT) analysis model. 
< 
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5.2.9 Effect ofEGCG on the Morphological Changes ofMyeloid Leukemia Cells 
In view of the potent anti-proliferative effects of EGCG on different myeloid 
leukemic cell lines as demonstrated in the Section 5.2.5, EGCG was further examined 
for its ability of induction of leukemic cell differentiation. The myeloid leukemia JCS 
� 
cells and HL-60 cells were chosen for our study as they are very sensitive to different 
inducers of cell differentiation (Breitman, 1990; Mak et aL, 1993). The leukemic cell 
differentiation was determined by the morphological analysis of the cytospin 
preparations of the EGCG-treated cells stained with the modified Wright-Giemsa 
stain. Despite its potent anti-proliferative effects, EGCG was found to have 
insignificant effect on inducing the blast cells (myeloblasts and promyelocytes) to 
differentiate into myelocytes or mature macrophage-like cells (Fig. 5.16, Fig. 5.17) 
under the prescribed experimental conditions. 
5.2.10 Effect ofEGCG-on the Endocytic Activity ofMyeloid Leukemia Cells 
It is well known that the differentiating myeloid leukemia cells not only exhibit 
morphological change but also show functional characteristics such as increase in 
endocytic activity. In this experiment, the endocytic activity of EGCG-treated myeloid 
leukemia cells was determined by the uptake of the FITC-conjugated bovine serum 
albumin (FITC-BSA), as measured by flow cytometry. As shown in Fig. 5.18 and 
Fig. 5.19, treatment of JCS cells and HL-60 cells did not show any significant 
increase in their endocytic activities. 
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Fig. 5.16 Effect ofEGCG on the Morphological Differentiation of JCS Cells. JCS 
cells (2000/well) were either (a) untreated or incubated with various concentrations of 
EGCG: (b) 10 i^M and (c) 15 i^M for 3 days. Cells were prepared by cytocentrifugation 
for morphological identification as described in Materials and Methods Section 
2.2.3.6.1. 
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Fig. 5.17 Effect of EGCG on the Morphological Differentiation of HL-60 Cells. 
HL-60 cells (1 x lOVwell) were either (a) untreated or incubated with various 
concentrations ofEGCG: (b) 5 ^M and (c) 10 i^M for 4 days. Cells were prepared by 
cytocentrifugation for morphological identification as described in Materials and 
Methods Section2.2.3.6.1. 
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Fig. 5.18 Effect ofEGCG on the Induction ofthe Endocytic Activity in JCS Cells. 
JCS cells (1 X 10' cells/ml) were incubated with EGCG (20 i^M) at 37�C for 3 days. 
Endocytic activity was determined by the uptake ofFITC-BSA, using untreated ceUs as 
a control. The paraformaldehyde-fixed cells (1 x 10^  cells) were analyzed for 
fluorescence intensity using the FACSort flow cytometer. The x-axis was plotted in a 
logarithmic scale. 
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Fig. 5.19 Effect ofEGCG on the Induction ofthe Endocytic Activity in HL-60. 
HL-60 cells (5 x 10^  cells/ml) were incubated with EGCG (15 i^M) at 3TC for 4 days. 
Endocytic activity was determined by the uptake ofFITC-BSA, using untreated cells as 
a control The paraformaldehyde-frxed cells (1 x 10^  cells) were analyzed for 
fluorescence intensity using the FACSort flow cytometer. The x-axis was plotted in a 
logarithmic scale. 
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5.3 Discussion 
The host immune system is a very important defence mechanism against tumour 
growth in the body. In this chapter, green tea catechins were shown to exhibit 
suppressive effect on the growth of two transplantable tumours (JCS and EAT cells) 
1 . 
in vivo. Although the mechanisms by which GTCs can exert their anti-tumour effects 
in vivo remain unclear, it is possible that GTCs may exert their effects by 
augmentation of the host immune response. Many reports have shown that the anti-
tumour activities of low molecular weight polyphenolic compounds are mediated 
through enhancing the activities of effector cells in the immune system. For example, 
a synthetic flavonoid, flavone acetic acid, was found to exhibit dose-dependent in vivo 
anti-tumour activity against solid tumours in mice by enhancing NK cell activity in 
vivo (Homung & Back, et al., 1988; Homung & Young, et al., 1988). Whether the 
anti-tumour activity of GTCs was mediated by enhancing the induction and/or activity 
ofthe immune effector cHls has been investigated in the present study. 
Macrophages are important effectors cells which can be activated to become 
highly cytotoxic to lyse tumour cells. By producing various cytokines, macrophages 
can display enhanced phagocytic activity, increase in cell killing capability and can 
activate helper T cells (White, 1996). The findings in Chapter 4 showed that GTCs 
could enhance the phagocytic activity of TG-elicited macrophages as well as 
enhancing the cytostatic activity of the PLA-activated macrophages against tumour 
cells in vitro. This anti-tumour activity was also increased by in vivo administration of 
GTCs. Previous work done by Sakagami et al. (1995) demonstrated that the 
epicatechin isomer EGCG can stimulate the production of TNF and IL-1 by human 
peripheral blood mononuclear adherent cells. Taken together, it is conceivable that the 
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anti-tumour activity of GTCs may be due to activation of macrophages which produce 
soluble factors such as TNF-a and IL-1. The exact mechanism is still not well 
understood and remains to be elucidated. 
� In the present study, in vivo administration of GTCs was shown to be able to 
enhance the cytotoxic activity ofNK cells against the NK-sensitive YAC-1 target cells 
in vitro. Early experiments done by Ikeda et al. (1984) demonstrated that (+)-catechin 
could significantly augment the mouse NK cell activity in dose-dependent manner. 
Similarly, previous work by Yan et al. (1992) showed that green tea extract could 
restore the NK cell activity in mice bearing SC-180 tumour. Mechanistic study on the 
augmenting effect of flavone acetic acid on NK cell activity indicated that the effect 
was due to the induction of interferon-a gene expression (Homung & Young, et al., 
1988). Whether GTCs act in a similar way is still unclear and needs further 
investigation. < 
LAK cells, which are generated in vitro by incubating peripheral blood 
lymphocytes in the presence of IL-2, are derived mainly but not exclusively from NK 
cells that lyse fresh tumour cells non-specifically (Dermime et al., 1995). Incubation 
of splenocytes with GTCs showed that GTCs alone was able to significantly induce 
LAK-like activity in vitro. Besides, GTCs were also capable of enhancing the IL-2-
induced LAK cytotoxicity. These findings are consistent with those reported by Hu et 
aL (1991), but an additive effect, instead of a synergistic effect of GTCs on IL-2-
induced LAK cytotoxicity was demonstrated in this study. The mechanisms by which 
GTCs can induce the LAK activity and enhance the effect of IL-2-induced LAK 
activity remain obscure. Moreover, whether GTCs can induce LAK activity in vivo 
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also remains to be determined. 
Another aspect of the anti-tumour activity of GTCs studied in this chapter is their 
direct inhibitory effect on the growth of tumour cells. Using the thymidine 
� 
incorporation assay, EGCG, the major epicatechin isomer in GTCs, was found to 
exhibit potent anti-proliferative effect on various tumour cell lines in a dose-
dependent manner. Our results are consistent with others who showed that EGCG 
could inhibit the growth of a wide variety of cancer cell lines, including hepatoma, 
erythroleukemia, melanoma, carcinoma of the breast, colon and lung etc. (Lea et al., 
1993; Valcic et al., 1996; Yang et al., 1998). Our data also showed that different 
tumour cell lines exhibited differential sensitivities to the growth-inhibitory effect of 
EGCG. Interestingly, the macrophage-like tumours were found to be relatively 
resistant to EGCG whereas the human myeloid leukemia (HL-60 cells) and a murine 
lymphoid tumour (YAG-1 cells) were shown to be most sensitive to EGCG. 
Moreover, the loss of cell viability at EGCG concentrations higher than 25 ^M 
suggested that this compound may not only have cytostatic but also have significant 
cytotoxic effect at higher concentrations. The anti-tumour activity of EGCG was 
further studied for its effect on the colony forming ability of two myeloid leukemia 
cells, JCS and HL-60. The results indicated that the anti-proliferative effect ofEGCG 
was associated with a reduction in the in vitro clonogenicity of the leukemia cells. The 
possible mechanisms by which EGCG can exert its anti-tumour effect in vitro are not 
fully understood, it has been suggested that green tea extracts, EGCG as well as other 
epicatechin isomers could inhibit the growth of various tumour cell lines by inhibiting 
the nucleoside transport, arresting cells at the G2/M phase of the cell cycle, or 
blocking the effects of growth factors on the tumour cells (Zhen et aL, 1991; Okabe et 
m  
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al., 1997; Asano et al, 1997). 
Apart from exhibiting significant anti-proliferative effect, EGCG was also found 
’ to be able to induce apoptotic cell death. At a concentration of 15 ^iM, EGCG could 
induce significant chromatin condensation, nuclear condensation, formation of 
apoptotic bodies and DNA fragmentation in a human myeloid leukemia cell line HL-
60 within 12 hours of incubation. Since the induction of apoptosis may be mediated 
through the regulation of cell cycle, the effect of EGCG on cell cycle perturbations 
was also investigated. Our results showed that EGCG could cause a marked decrease 
in cell cycling in S phase accompanied with a cell cycle rest in the Go/Gi phase in 
HL-60 cells within 12 hours of incubation. These data are consistent with that of 
Ahmad et al. (1997) who demonstrated that EGCG could cause Go/Gi phase arrest in 
carcinoma cells in a dose-dependent manner, but are different from that of Okabe et 
al. (1997) who showed that EGCG could arrest cell cycle progression at the G2/M 
phase. The exact mechanism by which EGCG can cause apoptotic cell death as well 
as cell cycle arrest is as yet poorly understood. It may be due to the modulation of 
signalling pathway or modulation of certain gene expression such as c-fos, c-myc and 
bcl-2 (Osuka et al., 1998; Chen et al., 1998; Ahmad et al., 1997). Therefore, the effect 
of EGCG on the expression of growth-related and appotosis-regulatory proteins on 
tumour cells are worthy of further investigations. 
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Tea is a very popular beverage derived from the evergreen plant Camellia sinesis, 
and has a very long history of cultivation and consumption for more than 2000 years. 
(Balentine et al., 1997). The Chinese valued tea for not only its pleasant flavour but also 
‘ its medicinal benefits. Traditionally, tea is claimed to have beneficial effects such as 
improvement of blood flow, elimination of alcohol and toxins, clearance and improved 
flow of urine, relief of joint pain and improved resistance to disease (Blofeld, 1985). 
Although the possible scientific basis for these diverse beneficial effects of drinking tea 
has not yet been fully understood, it becomes clear that most of the biological and 
pharmacological activities of tea is due to a group of low molecular weight polyphenolic 
compounds, collectively known as green tea catechins (GTCs). 
In the present study, GTCs were found to have significant, albeit low mitogenic 
effect on lymphocytes, an4 could markedly stimulate the lymphoproliferative response of 
lymphocytes to T cell mitogen such as Con A and to B cell mitogen such as LPS in vitro. 
Moreover, the in vivo administration of GTCs were also shown to be slightly mitogenic 
to lymphocytes and were able to enhance the proliferation of lymphocytes stimulated by 
B and T cell mitogens as well as the alloantigen. Apart from the stimulatory effect on 
non-specific lymphocyte proliferation, GTCs administered in vivo resulted in significant 
stimulation of cytotoxicity of alloreactive cytotoxic T lymphocytes as well as the effector 
T cell-mediated DTH response against SRBC . However, the stimulatory effect of GTCs 
on the primary humoral antibody response to SRBC was less well-defined. Similar 
finding was also done by Hu et al. (1993) and Zenda et aL (1997), who demonstrated the 
mitogenic activity of EGCG on lymphocytes especially the B cells. In contrast, a number  
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of previous reports showed that some polyphenolic fIavonoids inhibited lymphocyte 
proliferative response, IL-2 secretion by lymphocytes and polyclonal Ig production by B 
cells (Mookerjee et al., 1986; Devi et al., 1993; Sanbongi et al., 1997). This discrepancy 
� 
may be due to the dosage difference as suggested by Jung et al. (1983) who concluded 
that the immune cell behaviour could be bidirectionally influenced by the presence of 
flavonoids depending on their concentration in the medium. It has been proposed that the 
immunomodulating effect of polyphenols may be related to the phosphorylation of 
proteins associated with the cellular activation of lymphocytes (Middleton et aL, 1992). 
The enhancing function of EGCG was also found to be related to its special structure, the 
galloyl group (Hu et al., 1993). Therefore, further efforts are needed to elucidate the 
structural relationship of GTCs and the underlying mechanism of their modulatory effect 
on lymphocyte proliferation and function. 
The immunomodulatory activity of GTCs is not only restricted to lymphocytes. 
The activity and function of other immune cell types were also affected by GTCs. 
Macrophages are very important effector cells in the immune system. Our results showed 
that the in vivo administration of GTCs markedly increased the number of resident 
peritoneal macrophages and the migration of macrophages into the peritoneal cavity 
under the stimulation of protease peptone. The effector functions ofmacrophages, such as 
picolinic acid-activated cytostatic activity and the thioglycollate-elicited phagocytic 
activity, were significantly enhanced by in vitro exposure to GTCs. The in vivo 
administration of GTCs also augmented the cytostatic activity but not the phagocytic 
- activity. The stimulatory effect of GTCs on macrophages has been reported elsewhere in 
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which EGCG could stimulate the production of IL-l-like factor by human monocytes 
(Sakagami et aL, 1992; Miyamoto et al., 1997). Besides, the flavonoid Cianidanol was 
also reported to be able to increase the secretion ofIL-1 (Daniel et al., 1988). In view of 
， 
the stimulatory effect of GTCs on macrophage function, it is of interest to investigate 
whether GTCs can induce the production of cytokines by macrophages for regulating the 
host immune response as well as mediating the tumouricidal activities of macrophages. 
The mechanism of the stimulatory effect of GTCs on the in vivo migration of 
macrophages also remains to be investigated. Experiments should be conducted to 
investigate whether this stimulation is due to the increased secretion of soluble mediators 
or other cytokines by macrophages, or alternatively, due to an increased chemotactic 
response of macrophages under the influence of GTCs. Interestingly, the inhibitory effect 
of EGCG on NO production as well as the activity of inducible nitric oxide synthase had 
been previously reported (Chan et al., 1995). The molecular mechanism of such 
inhibitory effect has been attributed to the blocking of the activation of nuclear factor-KB 
which is necessary for the induction of iNOS transcription (Lin and Lin, 1997). The 
reason for the bidirectional effect of GTCs on macrophage activity still remains obscure 
and requires further investigation. 
In the recent decade, the anti-carcinogenic and anti-mutagenic properties of green 
tea has been under intensive investigation. In many animal models, it had been 
demonstrated that the in vivo administration of green tea or its polyphenolic constituents 
could afford protection against carcinogenesis induced by various carcinogens or 
ultraviolet radiation (Katiyar et aL, 1996; Weisburger et aI., 1997). Moreover, previous 
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experiments had shown that the in vivo administration of green tea extract could 
effectively inhibit the growth of tumours such as EAC，HAC and Lewis lung cancer (Yan 
et al., 1992; Zhu et al., 1997). The main constituent of green tea, EGCG, was also shown 
^ 
to inhibit the lung metastasis ofB16 melanoma cell lines (Taniguchi et al., 1992). In the 
present study, GTCs were found to exhibit < 10 folds (1 log) suppression of the growth of 
two transplantable tumours JCS and EAT, in vivo. The inhibitory effect on tumour 
growth might be, at least, in part, due to the enhancement of cytotoxic effector cells in the 
host immune system. Besides enhancing the activity of macrophages, GTCs were 
demonstrated to have an inductive effect on the non-specific cytotoxicity o f N K cells in 
vivo. Furthermore, GTCs alone could induce LAK activity by in vitro incubation with 
splenocytes, and augmented the IL-2-induced LAK cytotoxicity. The mechanism by 
which GTCs can activate NK activity remains obscure, but it may be due to the 
stimulation of cytokine gene expression for NK cell activation. It is also noteworthy that 
the augmenting effect of GTCs on the induction of LAK activity may have important 
implications in the “adoptive immunotherapy” of cancer. The concomitant use of GTCs 
along with IL-2 in adoptive immunotherapy may reduce the requirements for both the 
number of LAK cells and the dose of IL-2 for administration. Therefore, the toxicity due 
to the high doses of IL-2 and the massive reinfusion of LAK cells can be minimized 
without a loss in therapeutic efficacy. 
Apart from enhancing the host anti-tumour immune responses, GTCs were also 
shown to have direct inhibitory effect on the growth of tumour cells. The major and the 
most potent epicatechin isomer of GTCs, EGCG, was shown to have significant anti- -
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proliferative effect on different tumour cell lines. The anti-proliferative effect of EGCG 
was largely due to its cytostatic activity, as the incorporation of thymidine into the 
tumour cells was greatly diminished. Similar finding has been also reported elsewhere 
‘ that the green tea extract as well as the epicatechin isomers are able to inhibit the 
transport of nucleosides into the tumour cells required for DNA synthesis (Zhen et aL, 
1991; Lea et aL, 1993; Asano et al., 1997; Liang et al., 1997; Otsuka et aL, 1997). The 
possible use of nucleoside transport inhibitors in cancer chemotherapy has been currently 
investigated. As the transport is the initial step in the utilization of exogenous 
nucleosides, agents that inhibit nucleoside transport could be used to inhibit de novo 
synthesis of nucleotides by blocking the salvage pathways (Zhen et aL, 1983; Weber et 
al., 1987). These findings suggest the possible use of GTCs and the epicatechin isomers 
in cancer chemotherapy. 
< 
It has been suggested that tumour growth depends on evasion of normal control 
mechanisms that operate through a programmed deletion of cells i.e. apoptosis {Hall et 
al., 1994). Agents capable of modulating apoptosis and thereby affecting the steady-state 
cell population may therefore be useful in the management and therapy of cancer. In the 
present study, EGCG was found to induce marked apoptosis in the promyelocytic 
leukemia HL-60. The induction of apoptosis was also associated with the cell cycle arrest 
in the Go/Gi phase. Similar results have also been reported by Ahmad et al, (1997) and 
Okabe et al. (1997). Interestingly, the apoptosis and cell cycle arrest induced by EGCG 
has been recently shown to be specific only to the cancer cells but not in their respective 
normal counterparts (Ahmad et al., 1997; Chen et aL, 1998). The mechanism of this 
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differential apoptotic response might be the results of the enhancement of the expression 
of c-fos and c-myc genes by EGCG. Actually, the exact mechanism of apoptosis and cell 
cycle deregulation by EGCG has not been fully resolved. Efforts should be put on the 
� investigation of the signal transduction pathways such as the involvement of various 
cyclins, cyclin dependent kinases and their regulatory proteins as well as the expression 
of the related genes that operate on the Go/Gi phase of the cell cycle. 
It is well known that cell differentiation is tightly regulated in a cell cycle-
dependent manner. Differentiation of hematopoietic cells is associated with the loss of 
cell cycling capacity and, as a consequence, terminally differentiated cells are arrested in 
the Go/Gi phase (Fumkawa et aL, 1990). Although our results showed that EGCG was 
able to inhibit the proliferation, induced cell cycle arrest as well as suppressed the 
clonogenic ability of the^ myeloid leukemia JCS and HL-60 cells, nevertheless, our 
preliminary findings indicate that EGCG failed to have an effect on the induction of 
terminal differentiation of leukemia cells. Interestingly, a number of reports have shown 
that some naturally occurring flavonoids possess differentiation-inducing capacity. 
Previous work in our laboratory had demonstrated that flavone and 3 -hydroxyflavone 
were capable of inducing the differentiation of the myeloid leukemia JCS cells into 
mature macrophage-like cells (Kong, 1998). On the other hand, the isoflavone Biochanin 
A has been shown to induce the monocytic differentiation of JCS cells {Fung et al., 
1997). The other flavonoids such as quercetin, genistein, apigenin and luteolin were 
known also to have differentiation-inducing activity on different tumour cell lines (Weber 
et aL, 1997; Takahashi et al., 1998). In view of these findings, the possible 
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differentiation-inducing ability of other epicatechin isomers on tumour cells should also 
be examined in the future. 
‘ In conclusion, the results in this thesis project have shown that GTCs have the 
ability to enhance both the non-specific and the specific immune cell functions. GTCs 
were also demonstrated to exhibit anti-tumour activity in vivo. EGCG, the major and the 
most potent epicatechin isomer in GTCs, was also found to have direct anti-tumour 
activity by inhibiting the proliferation, inducing apoptotic death as well as cell cycle 
arrest of the human myeloid leukemia HL-60 cells. In addition to the findings of the anti-
carcinogenic activity of green tea, it is expected that green tea, especially its catechins 
constituents, may have therapeutic potential in the management of cancer. In future, 
further efforts are required to define more precisely the structure-function relationship of 
GTCs and their interactio^is with the cells of the immune system, and to elucidate the 
molecular mechanisms as well as the signalling pathways by which GTCs can exert their 
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